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ABSTRACT: The indium(III)-catalyzed cascade cycloisomeriza-
tion reaction of 1,5-enynes with pendant aryl nucleophiles is
reported. The reaction proceeds in cascade under mild reaction
conditions, using InI3 (5 mol %) as a catalyst with a range of 1,5-
enynes furnished with aryl groups (phenyl and phenol) at alkene
(E and Z isomers) and with terminal and internal alkynes. Using 1-
bromo-1,5-enynes, a one-pot sequential indium-catalyzed cyclo-
isomerization and palladium-catalyzed cross-coupling with triorga-
noindium reagents were developed. The double cyclization is
stereospecific and operates via a biomimetic cascade cation-olefin
through 1,5-enyne cyclization (6-endo-dig) and subsequent C−C
hydroarylation or C−O phenoxycyclization. Density functional
theory (DFT) computational studies on 1,5-enynyl aryl ethers
support a two-step mechanism where the first stereoselective 1,5-enyne cyclization produces a nonclassical carbocation intermediate
that evolves to the tricyclic reaction product through a SEAr mechanism. Using this approach, a variety of tricyclic heterocycles such
as benzo[b]chromenes, phenanthridines, xanthenes, and spiroheterocyclic compounds are efficiently synthesized with high atom
economy.
■ INTRODUCTION
The design of synthetic methodologies based on catalytic
cascade reactions constitutes an ideal tool for the construction of
complex molecules with high chemo-, regio-, and stereo-
selectivity.1 In particular, catalytic cascade cycloisomerization
reactions allow the synthesis of a large structural diversity of
molecules under complete atom economy and mild reaction
conditions. As an example, cascade polyene cyclizations are one
of the most impressive biosynthetic transformations known, and
their chemical emulation represents a major challenge in
modern synthetic chemistry.2 Usually, these transformations
involve the epoxide activation in a polyenic compound using
oxophilic Lewis acids under stoichiometric or catalytic
conditions.3 Alternatively, electrophilic alkyne activation under
metal catalysis has been recently envisaged as a different
synthetic approach to promote catalytic cascade polyenynic π-
cyclizations.4 The catalytic electrophilic activation of alkynes
promotes the addition of nucleophiles and allows the formation
of new carbon−carbon and carbon−heteroatom bonds in an
intermolecular and intramolecular manner. Although this
methodology has been associated with the use of carbophilic
late precious transition metals such as platinum5 or gold6 as
catalysts, main group metals such as gallium7 or indium8 have
been shown as valuable alternatives (Scheme 1a).
Indium(III) is a soft Lewis acid that exhibits a dual-mode
catalytic activity as σ-acid and π-acid, enabling both the
electrophilic activation of carbon−heteroatom and to carbon−
carbon unsaturated bonds.9 In addition, reactions involving
indium are used to provide high chemoselectivity and
substantial economical, environmental, and safety advantages.10
Along the years, these attractive chemical properties have been
exploited in classical synthetic transformations as oxophilic
Lewis acid either by using stoichiometric or catalytic
conditions.11 Recent contributions have demonstrated the
synthetic utility of indium(III) salts as carbophilic π-acid
catalysts in the electrophilic activation of alkynes.12
Metal-catalyzed 1,n-enyne cycloisomerization reactions con-
stitute a straightforward methodology for the synthesis of
polycyclic structures.13 In particular, gold(I)-catalyzed cyclo-
isomerization reactions of functionalized 1,5- and 1,6-enynes
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have been widely explored for the synthesis of polycyclic organic
compounds.14 On the other hand, indium(III)-catalyzed enyne
cycloisomerization reactions were first reported by Chatani,15
and more recently, Corey described the stereoselective synthesis
of complex chiral polycyclic molecules by cascade cyclo-
isomerization of chiral aryl polyenynes under indium(III)
catalysis.16a In this contribution, the catalytic activity of In(III)
as π-acid for the electrophilic activation of alkynes is remarked
and attributed to the vacant 5s and 5p orbitals, which might lead
to coordinate the C−C triple bond by bidentate complexation.
Later on, Corey also reported the superior catalytic activity of
diiodoindium(III) cation (InI2
+), generated by the addition of
Ag(I) salts to InI3.
16b
As part of a long-term research on indium chemistry,17 our
group has recently reported intramolecular hydroarylation and
hydroalkoxylation reactions and sequential indium-catalyzed
polyyne reactions under indium(III) catalysis (Scheme 1b).18
Herein, we report the In(III)-catalyzed cascade cycloisomeriza-
tion reactions of 1,5-enynes (E and Z isomers) furnished with
aryl nucleophiles and density functional theory (DFT) studies
about the mechanism of the reaction and the nature of the
organoindium intermediates involved (Scheme 1c).
■ RESULTS AND DISCUSSION
Our investigation started with the cycloisomerization reaction of
(E)-1,5-enynyl aryl ether 1a under In(III) catalysis. This
substrate was chosen to measure the indium alkynophilicity,
the regioselectivity of the reaction (6-endo vs 5-exo), and to
establish comparisons with other metal catalysts.14a In our first
experiments, we found that the treatment of (E)-1awith 5mol %
InI3 in 1,2-dichloroethane (DCE) at 60 °C resulted in the
stereoselective formation of the tricyclic compound 2a in 58%
yield after 5 h as the only isolated product as a separable mixture
of diastereoisomers (cis/trans = 25:75, Table 1, entry 1).
Alternatively, the use of InBr3 (5 mol %) also provided 2a in
similar yield and diastereoselectivity, whilst InCl3 (5 mol %)
resulted to be ineffective (entries 2 and 3, respectively). In all
cases, trans-fused 2a was identified as the major diastereoisomer
and its formation can be explained by a double regioselective 6-
endo-dig/endo-trig cyclization in cascade.
The stereoselectivity of this In(III)-catalyzed 1,5-enyne
cycloisomerization was then studied under different reaction
conditions. In this endeavor, we found that the reaction also
takes place with 2 mol % of InI3 in similar stereoselectivity but
longer reaction times (55%, cis/trans = 31:69, entry 4).
Interestingly, the yield, stereoselectivity, and reaction time
were slightly improved using toluene as a solvent (65%, cis/trans
= 11:89, entry 5). The reaction also proceeds at room
temperature using 20 mol % of InI3 in toluene or dichloro-
methane (DCM) with similar results (entries 6 and 7), but no
reaction was observed at −20 °C (entry 8). Surprisingly, the
combination of InI3 (5mol %) with the halide abstractor AgSbF6
(5 mol %) to generate the diiodonium cation (InI2
+) gave a new
major tricyclic product (I) concomitant with 2a (I:2a = 4:1
ratio) as a separable mixture in a combined 72% isolated yield
(entry 9). The formation of compound I, as amixture of cis/trans
(11:89) diastereoisomers, can be explained by ether cleavage,
Friedel−Crafts C-alkylation, and 1,5-enyne phenoxycyclization
reaction. In a similar pathway, treatment with In(NTf2)3 (5 mol
%) resulted in the formation of the bicyclic compound II (63%
yield, entry 10) with an alkene phenoxycyclization as the last
step. The use of In(OTf)3 as a catalyst resulted in decomposition
(entry 11). No reaction was observed employing In(acac)3 as
the catalyst, recovering the starting 1,5-enyne 1a (entry 12). In
Scheme 1. Indium(III)-Catalyzed Electrophilic Activation of
Alkynes












1 InI3 DCE 60 5 58 25:75
2 InBr3 DCE 60 20 53 33:67
3 InCl3 DCE 60 48
d
4 InI3
e DCE 60 24 55 31:69
5 InI3 toluene 60 2 65 11:89
6 InI3
f toluene rt 6 62 20:80
7 InI3
f DCM rt 7 63 19:81
8 InI3
f DCM −20 24 d
9 InI3
g DCE 60 5 72h
10 In(NTf2)3 DCE 60 5 63
i
11 In(OTf)3 DCE 60 24
j
12 In(acac)3 DCE 60 48
d
aMonitored by thin-layer chromatography (TLC). bIsolated yield.
cDetermined by gas chromatography−mass spectrometry (GCMS).
dNo reaction observed. e2 mol %. f20 mol %. gAgSbF6 (5 mol %) as a
cocatalyst. hMixture of products I:2a (4:1 ratio). iCompound II was
isolated. jDecomposition.
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this optimization process, the important role of the catalyst
counteranion is noteworthy, confirming InI3 as the most
efficient π-catalyst. Although different solvents can be used,
toluene was the solvent of choice for this 1,5-enyne cyclization.
The high chemoselectivity of InI3 in the electrophilic activation
of the alkyne over the ether cleavage is remarkable.
To further study the chemo-, regio-, and stereoselectivity and
access to novel functionalized benzo[b]chromenes, our
investigation was extended to 1,5-enynes functionalized at the
arene and alkyne units and with different alkene geometries.
Under the previously optimized reaction conditions, we were
pleased to find that the reaction of 1,5-enyne (E)-1b furnished
with a methyl group at the terminal alkyne proceeded
successfully to give trans-2b in 68% yield as a separable
diastereoisomeric mixture (cis/trans = 22:78, Table 2, entry 2).
This synthetic transformation was more efficient and selective
than using Hg(II), probably due to the softer Lewis acid
character of In(III).14a Interestingly, the reaction using 1-
bromo-1,5-enyne (E)-1c also provided 7-bromobenzo[b]-
chromene trans-2c diastereoselectively in good yield (62%,
cis/trans = 27:73, entry 3). The synthesis of trans-2c should
allow access to a variety of substituted benzo[b]chromenes by
metal-catalyzed cross-coupling reactions.17
The role of electronic effects was examined using phenyl 1,5-
enynyl ether (E)-1d. Interestingly, under the previously
developed reaction conditions, the double cycloisomerization
proceeded with complete stereochemical inversion giving rise to
the cis-benzo[b]chromene cis-2d as a single diastereoisomer by
1H NMR (61% yield, Table 2, entry 4). The isomerization
suggests a two-step mechanism, where the lower nucleophilicity
of the phenyl group facilitates the stereochemical inversion after
the first 6-endo-dig cycloisomerization reaction to produce the
most thermodynamically stable diastereoisomer.
Prompted by these interesting results, we studied the
influence of alkene stereochemistry on the reactivity, regio-,
and stereoselectivity. Previous metal-catalyzed 1,5-enyne cyclo-
isomerization reactions have shown a divergent outcome based
on the alkene geometry.14c In our case, the In(III)-catalyzed
cycloisomerization with (Z)-1a also proceeded with 6-endo
regioselectivity without isomerization providing the cis-2a as a
single diastereoisomer as determined by 1H NMR in 64% yield
(Table 2, entry 5). The same regiochemistry and stereochemical
outcomes were observed using 1-bromo-1,5-enyne (Z)-1c
(entry 6). Interestingly, the reaction with 1,5-enyne (Z)-1d
also proceeded with full retention of the stereochemistry to
obtain cis-2d as the only diastereoisomer as established by 1H
NMR (entry 7). These results point out at least three reactivity
patterns: the reaction is stereospecific through a two-step
mechanism; electronic effects affect the stereochemical out-
come; and the cis stereoisomer is thermodynamically more
favorable.
After these interesting results, we explored the reaction with
1,5-enynyl phenyl N-tosylamines, substrates of interest for the
synthesis of nitrogen heterocycles such as phenanthridines or
indoles. In this venture, we found that the reaction of 3,5-
dimethoxyphenyl 1,5-enynyl N-tosylamine (E)-3a with InI3 (5
mol %) in toluene at 60 °C gave the phenanthridine trans-4a in
90% yield in just 2 h as the only diastereoisomer detected by 1H
NMR (Table 3, entry 1). Analogously, the reaction with 1,5-
enynes (E)-3b and (E)-3c furnished with a methyl and a phenyl
group at the alkyne afforded phenanthridines trans-4b and trans-
4c stereoselectively as the only isolated products in 85 and 82%
yield (Table 3, entries 2 and 3, respectively). Furthermore, the
reaction with 1-bromo-1,5-enyne (E)-3d led to the 7-bromo-
hexahydrophenanthridine trans-4d in 73% yield (entry 4).
Although no isomerization was detected with these 1,5-enynes,
the reaction of (E)-1,5-enyne 3e, furnished with an unsub-
stituted phenyl group, proceeded with complete inversion and
the cis-4e was obtained as a single diastereoisomer (49% yield,
entry 5). As previously reported, the isomerization can be
explained by a stepwise mechanism where after the first 6-endo-
dig cyclization, the synthetic intermediate could isomerize
toward the most thermodynamically stable polycyclic com-
pound. Therefore, we can conclude that aryl 1,5-enynes 3a−d
furnished with the N-tosylamine moiety are more reactive than
Table 2. Indium-Catalyzed Reactions with 1,5-Enynyl Aryl
Ethers 1a−dc
aMajor isolated diastereomer. bIsolated yield. cMeasured by 1H
NMR.
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the ethers 1a−d and the cycloisomerization reaction takes place
with complete retention of the alkene configuration.
The stereospecificity of the cycloisomerization reaction was
also explored with the Z-alkene analogues. In this case, we
observed that the reaction with 1,5-enyne (Z)-3a afforded
phenanthridine cis-4a as a single diastereoisomer in 88% yield
(entry 6). Analogously, the reaction with bromoalkyne (Z)-3d
provided phenanthridine cis-4d in 72% yield (entry 7) and the
reaction with 1,5-enyne (Z)-3e without methoxy groups at the
phenyl unit gave cis-4e in 63% yield (entry 8). As previously
observed with the 1,5-enynyl ether (Z)-1d, in this case, the
reaction proceeded with full retention of the alkene stereo-
chemistry. Finally, we also explored the reaction with (E)-1,5-
enyne 3f, where the alkene moiety is disubstituted. Gratifyingly,
the cascade cycloisomerization proceeded with complete regio-
and stereospecificity to afford trans-4f in 79% yield as the only
detected and isolated product.19 This result demonstrates that
the cascade cycloisomerization reaction is not limited to
trisubstituted alkenes and resembles a biomimetic cascade
olefin process.
The synthetic utility of the In(III)-catalyzed double cyclo-
isomerization was then explored using 1,5-enynes equipped with
a phenol moiety. Although InI3 showed as an efficient catalyst for
the synthesis of benzo[b]furans from ortho-alkynylphenols,18d
this cascade cycloisomerization process found some synthetic
limitations using other transition metal catalysts.20 In addition,
the regioselective phenoxycyclization should provide access to
xanthenes, a tricyclic skeleton of a relevant class of natural
products.21
Using 1,5-enyne (E)-5a as a model substrate,20 we found that
InI3 (5 mol %) catalyzes the double cycloisomerization reaction
in toluene at room temperature to afford the tricyclic 6-endo-dig/
endo-trig product trans-6a in 86% isolated yield as a single
diastereoisomer in 5 h (Table 4, entry 1). It is interesting to note
the higher reactivity exhibited compared to the previous aryl 1,5-
enynyl ethers 1a−d and N-tosylamines 3a−f as well as the
chemical compatibility of the In(III) catalysis with the free
hydroxyl group of the phenol. Furthermore, the reaction with
(Z)-5a provided the cis-fused xanthene cis-6a in an excellent
yield of 87% as the only isolated product (entry 2). These
experimental results could be explained either by a stereospecific
concerted or by a stepwise mechanism.
As the next step, we also tested the reaction of aryl 1,5-enynes
5 substituted at the alkyne. However, the complex synthesis of
these substrates led us to consider a sequential procedure based
on indium-catalyzed cascade cycloisomerization of the 1-
bromo-1,5-enyne (E)-5b14c and subsequent functionalization
by the cross-coupling reaction. With this approach in mind, we
found that the reaction of 1-bromo-1,5-enyne (E)-5b and (Z)-
5b with InI3 (5 mol %) results in a stereospecific manner,
affording the expected 1-bromo-tetrahydroxanthenes trans-6b
and cis-6b in 89 and 92% yield, respectively, as the only isolated
products (Table 4, entries 3 and 4).
Having demonstrated the feasibility of both alkene isomers of
1-bromo-1,5-enyne 5b in the double cycloisomerization
reaction, we assayed the one-pot sequential indium(III)-
catalyzed 1,5-enyne cyclization and palladium-catalyzed cross-
coupling reaction using triorganoindium reagents.17,22 Gratify-
ingly, the treatment of (E)-5b with InI3 (5 mol %) in toluene at
room temperature followed by addition of a solution of Ph3In
(70mol %) and Pd(PPh3)4 (5mol %) in tetrahydrofuran (THF)
at 80 °C afforded the 4-phenyltetrahydroxhantene trans-6c in
76% yield (Scheme 2). The sequential protocol usingMe3In and
n-Bu3In also gave the xanthene derivatives trans-6d and trans-6e
in 83 and 81% yield, respectively. These results show the
versatility of the In-catalyzed cascade cycloisomerization
Table 3. Indium-Catalyzed Reactions of 1,5-Enynyl Aryl N-
Tosylamines 3a−f
aIsolated yield.
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reaction using aryl 1,5-enynes and its chemical compatibility
with Pd-catalyzed cross-coupling reactions.
Finally, the indium-catalyzed cycloisomerization reaction of
1,5-enynes with aryl nucleophiles at the C-5 alkene unit (7a−c)
was also briefly studied (Table 5). These substrates should allow
the synthesis of spiroheterocycles if the cycloisomerization
proceeds with 6-endo regioselectivity according to the previously
described cation-olefin mechanism.14a Interestingly, the treat-
ment of 1,5-enyne 7a with InI3 (5 mol %) in toluene at 60 °C
afforded oxaspirane 8a as the only isolated product in an
excellent yield of 84% (Table 5, entry 1). As expected, the
cascade cycloisomerization reaction proceeded with 6-endo-dig/
endo-trig regioselectivity to afford the Markovnikov product
exclusively. Analogously, the reaction using 1,5-enynyl benzylN-
tosylamine 7b provided the azaspirane 8b in 92% yield (entry 2).
The reaction with 1-bromo-1,5-enyne 7c afforded the
corresponding spirane 8c in 76% yield (entry 3). In addition,
the one-pot sequential indium-catalyzed cycloisomerization of
7c followed by the cross-coupling reaction with Ph3In using
Pd(PPh3)4 as the catalyst provided the phenyl-substituted
azaspirane 8d in 61% overall yield (two steps, entry 4).
Mechanistic Studies. According to the experimental
results, we postulate that the course of the indium(III)-catalyzed
double cascade cycloisomerization could be viewed as either a
concerted process or a stepwise route depending on the arene
nucleophilicity (Scheme 3). In a two-step mechanism, we
postulate that the initial η2 coordination of the indium(III)
halide with the alkyne moiety (C) would trigger 1,5-enyne
cyclization to form the intermediate D.2 This intermediate
should not be a pure carbocation and could be seen as a
resonance hybrid of two resonance structures, an indium-
stabilized homoallylic carbocation (D) and a cyclopropylindium
ylide. Once there, the second cyclization should proceed
through a Friedel−Crafts type alkylation reaction, subsequent
aromatization and protodemetallation should provide the
corresponding tricyclic compound, regenerating the catalytic
species (Scheme 3). The mechanistic pathway and the nature of
the transition states and synthetic intermediates should also
depend on the substituents at the alkene, alkyne, or arene units.
Our experimental data show that the In(III)-catalyzed double
cycloisomerization reaction of aryl-substituted (Z)-1,5-enynes is
stereoselective, yielding in all cases the cis adducts with
Table 4. Indium-Catalyzed Phenoxycyclization of 1,5-Enynes
5a−b
aIsolated yield.
Scheme 2. Sequential One-Pot In-Catalyzed 1,5-Enyne
Cycloisomerization and Pd-Catalyzed Cross-Coupling
Reaction with (E)-5b
Table 5. Synthesis of Spiroheterocycles by Indium-Catalyzed
Reaction with 1,5-Enynes 7a−cc
aIsolated yield. bObtained from 7c by sequential In-catalyzed
cycloisomerization and Pd-catalyzed cross-coupling. cOverall yield
(two steps).
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complete selectivity. For example, independently of the
electronic nature of the aromatic ring, the final cis-products
are obtained, cis-2a, cis-2c, and cis-2d from (Z)-1a, (Z)-1c, and
(Z)-1d, respectively (Table 2, entries 5−7), as for the 1,5-enyne
cycloisomerizations of Table 3 (entries 6−8) and Table 4.
Accordingly, one would expect that using (E)-1,5-enynes, the
tricyclic products would belong to the trans series. In fact, this is
true for all of the dimethoxyphenyl, electron-rich arenes, 1,5-
enynes like (E)-1a (Table 2, entry 1, cis/trans = 11:89), and
others (Table 2, entries 1−3; Table 3, entries 1−4; Table 4).
However, surprisingly, the unsubstituted phenyl 1,5-enynes (E)-
1d and (E)-3e break this rule, affording the opposite cis
diastereoisomers of the final adduct cis-2d (Table 2, entry 4) and
cis-4e (Table 3, entry 5). In other words, phenyl ether 1,5-
enynes 1d and 3e lead diastereoselectively to the cis final
adducts, regardless of the E or Z configuration of the initial
double bonds. To gain insights into the intriguing behavior of
aryl 1,5-enynyl ethers (E)-1d and (E)-3e, we set out to study the
reaction theoretically.23
Computational studies24 for (Z)- and (E)-1,5-enynyl aryl
ether 1a (Scheme 4) showed that the formation of the first cycle
occurs via TS1-Z or TS1-E, two transition states originated by
the nucleophilic 6-endo-dig alkene attack to the indium-activated
electrophilic triple bond. The activation energy is very similar for
the two compounds, 17.3 and 18.9 kcal/mol, respectively. As
expected, the aromatic ring does not participate in the formation
of the first ring, which affords intermediates INT1 stereospecifi-
cally, INT1-cis from Z, and INT1-trans from E startingmaterials.
These intermediates are low in energy, 0.3−1.8 kcal/mol,
presenting a bicyclic structure [4.1.0] and a partial indium
carbene character. The computational data shows that the first
step (TS1) is rate limiting since the formation of the second
cycle by an electrophilic aromatic substitution in TS2-type
transition states proceeds with lower activation energies, 8.9 for
TS2-cis and 12.6 kcal/mol for TS2-trans. As expected for this
Scheme 3. General Plausible Mechanism for the In(III)-
Catalyzed Cascade Cycloisomerization Reaction of 1,5-
Enynes 1a−d and 3a−f
Scheme 4. DFT-Calculated Mechanism of the Reaction of (Z)-1a and (E)-1a for the Selective Formation of INT2-cis and -trans
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type of reaction (SEAr), electron-rich arenes are positively
affected by the stabilization of the incipient positive charge in the
aryl ring by the electron-releasing methoxy groups. For the same
reason, the arenium intermediates INT2a (cis and trans) are very
stable in the presence of methoxy substituents (−12.3 and −7.6
kcal/mol). Although we did not compute them, the easy final
deprotonation and hydrolysis (protodemetallation) of the C−In
bond after INT2a intermediates would render exclusive adducts
cis-2a (from Z-1a, black pathway in Scheme 4) and trans-2a
(from E-1a, red line), in complete agreement with the
experimental results.
Intermediate INT1 presents very interesting structures, as
they can be described by two resonance forms, I and II (Scheme
5, top). The former is a fused bicyclic skeleton with a polarized
C−In bond, whilst II shows the zwitterionic character, with the
positive charge on the methylated tertiary carbon and an anionic
alkenyl-indium motif. The NBO analysis of INT1(OMe) and
INT1(H) affords Wiberg bond orders showing the mixed
character of both structures, slightly more akin to structure I,
since the internal C−C bond b is advanced but not completely
formed (BO = 0.67−0.81), and the C−C bond a presents slight
but not complete double bond character (BO = 1.33−1.43).
The bonding distances also show mixed characteristics of both
resonance forms, with computed values of δa = 1.40 Å and δb =
1.68 Å. Thus, resonance form II also has a significant
participation in the actual structure of these intermediates. We
rationalized that, given the weakness of bond b and the partial
carbocationic character at the C-3 position (Scheme 5, bottom),
the bicyclic species INT1-cis and INT1-trans could potentially
interconvert by an isomerization equilibrium. Indeed, a
transition state was located (TS-isom) bearing an almost planar
tertiary carbocation, where the adjacent carbon (labeled as C-3)
is flipping between the upper and lower faces of the cyclohexene
plane (Scheme 5). The activation energy of this process is quite
low, ca. 13.5−15.1 kcal/mol, making the isomerization plausible,
at least in some circumstances. However, as mentioned before
for, the 1a starting materials, the second step (TS2) is low
enough in energy (8.9 and 12.6 kcal/mol, Scheme 4) to
outcompete the isomerization, providing a complete selectivity
(experimental > 95:5) for the cis and trans final products.
The scenario is quite different for 1,5-enynes (E)- and (Z)-1d
without methoxy groups (Scheme 6). The initial cyclization
through TS1 is also rate limiting, with values of 17.4 and 19.6
kcal/mol. After the first transition state, the structure and
energies of INT1 intermediates are very similar to the previous
ones. However, due to the absence of stabilizingmethoxy groups
in the aromatic ring, the second cyclization (TS2) increases its
energy significantly in ca. 5−7 kcal/mol (12.8 and 19.1 kcal/
mol, Scheme 6) above the values noted for 1a. This fact is
Scheme 5. DFT-Calculated Isomerization Process between
the Intermediates INT1-cis and INT1-trans
Scheme 6. DFT-Calculated Mechanism of the Reaction of (Z)-1d and (E)-1d under Curtin−Hammett Conditions
The Journal of Organic Chemistry pubs.acs.org/joc Article
https://doi.org/10.1021/acs.joc.1c00825
J. Org. Chem. 2021, 86, 9515−9529
9521
especially important in the case of the trans cyclization, which
also shows larger ring strain, producing a sluggish cyclization
(19.1 kcal/mol), which becomes slower than the isomerization
(15.1 kcal/mol) between the two INT1 isomers. Therefore,
intermediate INT1-trans prefers to isomerize to INT1-cis rather
than cyclize, and the reaction follows the red line in Scheme 6 to
cis isomer. Meanwhile, the double cyclization of the Z isomer
proceeds via the black line to lead stereospecifically to the cis
isomer. These observations can explain how both starting
materials converge in INT1-cis to give the same cis final isomer
under Curtin−Hammett conditions.
■ CONCLUSIONS
Indium(III) iodide is an efficient catalyst to promote a double
cycloisomerization reaction of 1,5-enynes with pendant aryl
nucleophiles. The reaction can be performed under mild
reaction conditions using 5 mol % of catalyst and proceeds in
cascade through alkyne electrophilic activation with complete 6-
endo regioselectivity via a biomimetic cascade cation-olefin
process. In some cases, the double cycloisomerization is
stereospecific with the retention of the alkene configuration.
In addition, the synthetic transformation is highly versatile,
allowing 1,5-enynes substituted at the alkyne and alkene units
and phenyl groups and phenol derivatives as nucleophiles.
Accordingly, a diverse group of polycyclic heterocycles such as
benzo[b]chromenes, phenanthridines, xanthenes, and spirohe-
terocyclic compounds was synthesized. Computational studies
on aryl 1,5-enynyl ethers support a mechanism consisting of two
consecutive cyclizations: the first one is a 6-endo-dig process
catalyzed by a regioselective alkyne electrophilic activation and a
second cyclization through a nonstereospecific SEAr process.
■ EXPERIMENTAL SECTION
General Methods. All reactions were carried out in flame-dried
glassware under argon using standard gastight syringes, cannulae, and
septa. Toluene and THF were distilled from sodium/benzophenone.
Dry MeOH, DCE, Et3N, and other commercially available reagents
were used as received. Reaction temperatures refer to external bath
temperatures. Butyllithium was titrated prior to use. Indium(III) iodide
(99.998%) and indium(III) bromide (99.999%) were purchased from
Aldrich and used as received under argon. The reactions were
monitored by TLC using precoated silica gel plates (Alugram Xtra
SIL G/UV254, 0.20 mm thick), UV light as the visualizing agent, and
ethanolic phosphomolybdic acid as the developing agent. Flash column
chromatography was performed with 230−400 mesh silica gel. 1H and
13C NMR spectra were recorded in CDCl3 at 300 K using a Bruker
Advance 300 MHz, 400 MHz or a Bruker Advance 500 MHz
spectrometer and calibrated to the solvent peak. Mass spectra were
obtained with a MAT 95XP Magnetic Sector EI spectrometer or with a
QSTAR Elite hybrid quadrupole time-of-flight (TOF) ESI mass
spectrometer, both operating in the positive ionization mode. Gas
chromatography (GC) was performed on a Trace 1300 autosampling
GCwith a TG-5SILMS capillary column and equipped with an ISQQD
mass spectrometer.
(E)-1,3-Dimethoxy-5-[(3-methyloct-2-en-6-yn-1-yl)oxy]-
benzene [(E)-1b].14a To a cooled solution of enyne (E)-1a14c (202.8
mg, 0.78 mmol) in dry THF (10 mL) at 0 °C, n-BuLi (0.38 mL, 0.82
mmol, 2.19M in hexanes) was added dropwise. After 30min,MeI (0,06
mL, 0.94mmol) was added, and the reactionmixture was stirred for 2 h.
The reaction was quenched with EtOH (1 mL), the solvent was
evaporated, and the corresponding residue was purified by flash
chromatography (2% EtOAc/hexanes) to afford (E)-1b (162.6 mg,
76%) as a colorless oil; 1H NMR (300 MHz, CDCl3) δ 6.11−6.09 (m,
3H), 5.54−5.50 (m, 1H), 4.51 (d, J = 6.5 Hz, 2H), 3.77 (s, 6H), 2.26
(m, 4H), 1.77 (s, 3H), 1.74 (s, 3H); 13C{1H} NMR (75 MHz, CDCl3)
δ 161.6, 160.9, 139.9, 120.5, 93.7, 93.1, 78.6, 76.2, 65.0, 55.5, 39.0, 17.7,
16.7, 3.6; HRMS (ESI) m/z: [M + Na]+ calcd for C17H22O3Na
297.1461; found 297.1458.
(E)-1-[(7-Bromo-3-methylhept-2-en-6-yn-1-yl)oxy]-3,5-di-
methoxybenzene [(E)-1c].To a room temperature solution of (E)-3-
methylhept-2-en-6-yn-1-ol25 (105.7 mg, 0.85 mmol) in acetone (5
mL),N-bromosuccinimide (NBS) (166.7 mg, 0.93 mmol) and AgNO3
(15.8 mg, 0.09 mmol) were added and the reaction mixture was stirred
for 1 h. The reaction mixture was diluted with Et2O (10 mL), washed
with H2O (10 mL) and brine (10 mL), dried with anhydrous MgSO4,
filtered, and concentrated in vacuo to afford (E)-7-bromo-3-
methylhept-2-en-6-yn-1-ol as an orange oil, which was used in the
next step without further purification. The crude product was added to
a solution of triphenylphosphine (329.4 mg, 1.25 mmol) and 3,5-
dimethoxyphenol (193.2 mg, 1.25 mmol) in THF (10 mL). To this
solution at 0 °C, diisopropyl azodicarboxylate (DIAD) (0.25 mL, 1.25
mmol) was added dropwise and the reaction mixture was stirred for 5 h
at 60 °C. Then, the solvent was evaporated in vacuo and the
corresponding residue was purified by flash chromatography (5%
EtOAc/hexanes) to afford (E)-1c (161.0 mg, 56% in two steps) as a
yellow oil; 1HNMR (300MHz, CDCl3) δ 6.10 (m, 3H), 5.54−5.50 (m,
1H), 4.50 (d, J = 6.6 Hz, 2H), 3.76 (s, 6H), 2.36−2.29 (m, 4H), 1.74 (s,
3H); 13C{1H} NMR (75 MHz, CDCl3) δ 161.6, 160.8, 139.1, 120.9,
93.7, 93.1, 79.6, 64.8, 55.4, 38.6, 38.0, 18.6, 16.6; IR (neat) νmax 2929,
2841, 1594, 1460, 1204, 1150, 1062, 819 cm−1; HRMS (ESI) m/z: [M
+ Na]+ calcd for C16H19BrO3Na 361.0409; found 361.0416.
(E)-[(3-Methylhept-2-en-6-yn-1-yl)oxy]benzene [(E)-1d].To a
0°C solution of (E)-3-methylhept-2-en-6-yn-1-ol25 (201.9 mg, 1.63
mmol), triphenylphosphine (640.0 mg, 2.44 mmol) and phenol (229.6
mg, 2.44 mmol) in THF (10 mL), DIAD (0.48 mL, 2.44 mmol) was
added dropwise. The reaction mixture was stirred for 5 h at 60 °C in an
oil bath and the solvent was evaporated in vacuo. Then, the
corresponding residue was purified by flash chromatography (5%
EtOAc/hexanes) to afford (E)-1d (251.4 mg, 77%) as a colorless oil;
1H NMR (300 MHz, CDCl3) δ 7.31−7.28 (m, 2H), 6.94−6.93 (m,
3H), 5.58−5.53 (m, 1H), 4.56 (d, J = 6.5 Hz, 2H), 2.35−2.31 (m, 4H),
1.95 (t, J = 2.3 Hz, 1H), 1.75 (s, 3H); 13C{1H}NMR (75MHz, CDCl3)
δ 158.9, 139.1, 129.5, 121.1, 120.8, 114.8, 83.9, 68.9, 64.7, 38.3, 17.3,
16.6; HRMS (EI) m/z: [M]+ calcd for C14H16O 200.1201; found
200.1196.
(Z)-1,3-Dimethoxy-5-[(3-methylhept-2-en-6-yn-1-yl)oxy]-
benzene [(Z)-1a]. DIAD (0.51 mL, 2.57 mmol) was added dropwise
at 0 °C to a solution of (Z)-3-methylhept-2-en-6-yn-1-ol26 (212.6 mg,
1.71 mmol), triphenylphosphine (674.1 mg, 2.57 mmol), and 3,5-
dimethoxyphenol (396.2 mg, 2.57 mmol) in THF (10 mL). The
reaction mixture was stirred for 3 h at 60 °C in an oil bath and the
solvent was evaporated in vacuo. Then, the corresponding residue was
purified by flash chromatography (5% EtOAc/hexanes) to afford (Z)-
1a (227.3 mg, 51%) as a colorless oil; 1H NMR (300 MHz, CDCl3) δ
6.11−6.09 (m, 3H), 5.60 (td, J = 6.8, 1.6 Hz, 1H), 4.51 (d, J = 6.8 Hz,
2H), 3.76 (s, 6H), 2.36−2.34 (m, 4H), 1.97 (t, J = 2.4 Hz, 1H), 1.81 (s,
3H); 13C{1H} NMR (75 MHz, CDCl3) δ 161.6, 160.7, 139.7, 122.0,
93.6, 93.0, 83.7, 69.0, 64.5, 55.4, 31.2, 23.3, 17.5; IR (neat) νmax 3289,
2935, 2840, 1593, 1474, 1204, 1147, 1060, 818 cm−1; HRMS (ESI)m/
z: [M + Na]+ calcd for C16H20O3Na 283.1304; found 283.1313.
(Z)-1-[(7-Bromo-3-methylhept-2-en-6-yn-1-yl)oxy]-3,5-di-
methoxybenzene [(Z)-1c]. To a room temperature solution of (Z)-
3-methylhept-2-en-6-yn-1-ol26 (115.7 mg, 0.93 mmol) in acetone (5
mL), NBS (182.4 mg, 1.02 mmol) and AgNO3 (17.3 mg, 0.10 mmol)
were added and the reaction mixture was stirred for 1 h. The reaction
mixture was diluted with Et2O (10 mL) and washed with H2O (10 mL)
and brine (10 mL), dried with MgSO4 (anhydrous), filtered, and
concentrated in vacuo to afford (Z)-7-bromo-3-methylhept-2-en-6-yn-
1-ol as an orange oil, which was used in the next step without further
purification. The crude product was added to a solution of
triphenylphosphine (354.0 mg, 1.35 mmol) and 3,5-dimethoxyphenol
(208.9 mg, 1.35 mmol) in THF (10 mL), DIAD (0.26 mL, 1.35 mmol)
at 0 °C was added dropwise, and the reaction mixture was heated at 60
°C for 5 h. Then, the solvent was evaporated in vacuo and the
corresponding residue was purified by flash chromatography (5%
EtOAc/hexanes) to afford (Z)-1c (149.9 mg, 47% in two steps) as a
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yellow oil; 1HNMR (300MHz, CDCl3) δ 6.11−6.09 (m, 3H), 5.61 (m,
1H), 4.49 (d, J = 6.7 Hz, 2H), 3.77 (s, 6H), 2.34 (m, 4H), 1.80 (s, 3H);
13C{1H} NMR (75 MHz, CDCl3) δ 161.5, 160.7, 139.5, 122.0, 93.6,
93.1, 79.5, 64.4, 55.4, 38.8, 31.0, 23.3, 18.8; IR (neat) νmax 2927, 2840,
1593, 1474, 1204, 1148, 1061, 818 cm−1; HRMS (ESI)m/z: [M +Na]+
calcd for C16H19BrO3Na 361.0409; found 361.0403.
(Z)-[(3-Methylhept-2-en-6-yn-1-yl)oxy]benzene [(Z)-1d]. To
a cooled solution of (Z)-3-methylhept-2-en-6-yn-1-ol26 (215.8 mg,
1.74 mmol), triphenylphosphine (684.6 mg, 2.61 mmol) and phenol
(245.6 mg, 2.61 mmol) in THF (10 mL) at 0 °C, DIAD (0.52 mL, 2.61
mmol) was added dropwise and the reaction mixture was stirred for 5 h
at 60 °C in an oil bath. The solvent was evaporated in vacuo and the
corresponding residue was purified by flash chromatography (5%
EtOAc/hexanes) to afford (Z)-1d (236.7 mg, 68%) as a colorless oil;
1H NMR (300 MHz, CDCl3) δ 7.31−7.25 (m, 2H), 6.95−6.91 (m,
3H), 5.62−5.60 (m, 1H), 4.55 (d, J = 6.8, 2H), 2.38−2.33 (m, 4H),
1.98−1.96 (m, 1H), 1.82 (s, 3H); 13C{1H} NMR (75 MHz, CDCl3) δ
158.8, 139.5, 129.5, 122.2, 120.8, 114.8, 83.8, 69.0, 64.3, 31.3, 23.3,
17.5; IR (neat) νmax 3292, 2917, 2868, 1598, 1494, 1235, 1172, 1006,
752 cm−1; HRMS (EI) m/z: [M]+ calcd for C14H16O 200.1201; found
200.1197.
(E)-N-(3,5-Dimethoxyphenyl)-4-methyl-N-(3-methyloct-2-
en-6-yn-1-yl)benzenesulfonamide [(E)-3b]. To a 0 °C solution of
1,5-enyne (E)-3a14c (205.6 mg, 0.50 mmol) in dry THF (10 mL), n-
BuLi (0.21 mL, 0.52 mmol, 2.5 M in hexanes) was added dropwise.
After 30 min, MeI (0,04 mL, 0.60 mmol) was added and the reaction
mixture was left stirring for 2 h. The reaction was quenched with EtOH
(3 mL), the solvent was evaporated, and the corresponding residue was
purified by flash chromatography (10% EtOAc/hexanes) to afford (E)-
3b (108.4 mg, 51%) as a white solid; 1H NMR (300 MHz, CDCl3) δ
7.56 (d, J = 8.4 Hz, 2H), 7.28−7.25 (m, 2H), 6.36 (d, J = 2.1 Hz, 1H),
6.20 (d, J = 2.1 Hz, 2H), 5.15 (t, J = 7.0 Hz, 1H), 4.13 (d, J = 6.9 Hz,
2H), 3.71 (s, 6H), 2.42 (s, 3H), 2.07 (m, 4H), 1.72 (s, 3H), 1.52 (s,
3H); 13C{1H} NMR (75 MHz, CDCl3) δ 160.5, 143.4, 141.3, 139.1,
135.8, 129.4, 127.9, 119.7, 107.0, 100.1, 78.5, 76.0, 55.5, 48.7, 38.8,
21.6, 17.7, 16.2, 3.5; HRMS (ESI) m/z: [M + H]+ calcd for
C24H30NO4S 428.1890; found 428.1893.
(E)-N-(3,5-Dimethoxyphenyl)-4-methyl-N-(3-methyl-7-phe-
nylhept-2-en-6-yn-1-yl)benzenesulfonamide [(E)-3c]. To a
solution of 1,5-enyne (E)-3a14c (163.0 mg, 0.39 mmol) in Et3N (4
mL), CuI (3.75mg, 0.02mmol), Pd(PPh3)2Cl2 (13.83mg, 0.02mmol),
and iodobenzene (103.4 mg, 0.51 mmol) were added and the reaction
mixture was stirred overnight at room temperature. Then, the reaction
was quenched with H2O (15 mL) and the aqueous phase was extracted
with Et2O (3 × 15 mL). The combined organic phase was washed with
brine (50 mL), dried with MgSO4 (anhyd.), filtered, and concentrated
in vacuo to afford (E)-3c (107.9 g, 57%) as an amorphous white solid
after purification by column chromatography (10% EtOAc/hexanes);
1H NMR (300 MHz, CDCl3) δ 7.56 (d, J = 8.2 Hz, 2H), 7.34 (dd, J =
6.7, 3.1 Hz, 2H), 7.27−7.24 (m, 5H), 6.35 (t, J = 2.3 Hz, 1H), 6.20 (d, J
= 2.3 Hz, 2H), 5.22 (t, J = 6.7 Hz, 1H), 4.15 (d, J = 6.8 Hz, 2H), 3.68 (s,
6H), 2.42 (s, 3H), 2.36 (t, J = 7.5 Hz, 2H), 2.20 (t, J = 7.5 Hz, 2H), 1.58
(s, J = 1.3 Hz, 3H); 13C{1H} NMR (75 MHz, CDCl3) δ 160.6, 143.5,
141.3, 138.9, 135.8, 131.6, 129.5, 128.3, 127.9, 127.7, 123.9, 120.1,
107.1, 100.2, 89.6, 82.2, 81.1, 55.5, 48.7, 38.5, 21.7, 18.6, 16.4; IR (neat)
νmax 2925, 2841, 1596, 1458, 1346, 1205, 1154, 1066, 663 cm
−1; HRMS




(125.0 mg, 0.70 mmol) and AgNO3 (12.0 mg, 0.07 mmol) were
added to a solution of the enyne (E)-3a (266.3 mg, 0.64 mmol) in
acetone (6 mL), and the reaction mixture was stirred for 1 h at room
temperature. The reaction mixture was diluted with Et2O (10 mL), the
organic phase was washed with H2O (10 mL) and brine (10 mL), dried
withMgSO4 (anhyd.), filtered, and concentrated in vacuo to afford, after
purification by column chromatography (15% EtOAc/hexanes), (E)-
3d (198.0 mg, 74%) as a yellow oil; 1HNMR (300MHz, CDCl3) δ 7.56
(d, J = 8.0 Hz, 2H), 7.28 (m, 2H), 6.37 (m, J = 2.3 Hz, 1H), 6.20 (d, J =
2.3 Hz, 2H), 5.16 (t, J = 6.7 Hz, 1H), 4.13 (d, J = 6.9 Hz, 2H), 3.71 (s,
6H), 2.42 (s, 3H), 2.16−2.10 (m, 4H), 1.55 (s, 3H); 13C{1H} NMR
(75 MHz, CDCl3) δ 160.6, 143.5, 141.3, 138.5, 135.9, 129.5, 127.9,
120.2, 107.1, 100.2, 79.6, 55.5, 48.6, 38.4, 38.0, 21.7, 18.7, 16.3; HRMS
(ESI) m/z: [M + Na]+ calcd for C23H26BrNO4SNa 514.0658; found:
514.0645.
(E)-4-Methyl-N-(3-methylhept-2-en-6-yn-1-yl)-N-phenyl-
benzenesulfonamide [(E)-3e]. DIAD (0.36 mL, 1.81 mmol) was
added dropwise at 0 °C to a solution of (E)-3-methylhept-2-en-6-yn-1-
ol25 (150.0 mg, 1.21 mmol), triphenylphosphine (474.7 mg, 1.81
mmol), and p-toluenesulfonanilide (447.6 mg, 1.81 mmol) in THF (10
mL). The reactionmixture was stirred for 5 h at 60 °C in an oil bath and
the solvent was evaporated in vacuo. The corresponding residue was
purified by flash chromatography (20% EtOAc/hexanes) to afford (E)-
3e (303.7 mg, 71%) as a colorless oil; 1H NMR (300 MHz, CDCl3) δ
7.51 (d, J = 8.3 Hz, 2H), 7.27−7.24 (m, 5H), 7.06−7.04 (m, 2H), 5.18
(ddt, J = 8.2, 6.9, 1.3 Hz, 1H), 4.19 (d, J = 7.0 Hz, 2H), 2.42 (s, 3H),
2.10 (m, 4H), 1.84 (m, 1H), 1.49 (s, 3H); 13C{1H} NMR (75 MHz,
CDCl3) δ 143.4, 139.4, 138.7, 135.8, 129.5, 129.0, 128.9, 127.9, 127.8,
120.1, 83.7, 68.8, 48.5, 38.1, 21.7, 17.3, 16.1; IR (neat) νmax 3295, 2972,
2922, 1598, 1494, 1345, 1156, 1091, 654 cm−1; HRMS (ESI) m/z: [M
+ Na]+ calcd for C21H23NO2SNa: 376.1341; found: 376.1338.
(Z)-N-(3,5-Dimethoxyphenyl)-4-methyl-N-(3-methylhept-2-
en-6-yn-1-yl)benzenesulfonamide [(Z)-3a]. DIAD (0.34 mL, 1.74
mmol) was added dropwise at 0 °C to a solution of (Z)-3-methylhept-
2-en-6-yn-1-ol26 (144.2 mg, 1.16 mmol), triphenylphosphine (456.4
mg, 1.74 mmol), and N-(3,5-dimethoxybenzyl)-4-methylbenzenesul-
fonamide27 (534.4 mg, 1.74 mmol) in THF (10 mL). The reaction
mixture was stirred for 5 h at 60 °C in an oil bath and the solvent was
evaporated in vacuo. The corresponding crude reaction product was
purified by flash chromatography (15% EtOAc/hexanes) to afford (Z)-
3a (359.8 mg, 75%) as a white solid; mp 100−102 °C; 1H NMR (300
MHz, CDCl3) δ 7.55 (d, J = 8.3 Hz, 2H), 7.28−7.25 (m, 2H), 6.37 (t, J
= 2.3 Hz, 1H), 6.20 (d, J = 2.3 Hz, 2H), 5.24−5.20 (m, 1H), 4.15 (dd, J
= 7.0, 1.2 Hz, 2H), 3.71 (s, 6H), 2.43 (s, 3H), 2.14−2.09 (m, 4H), 1.90
(m, 1H), 1.63 (s, 3H); 13C{1H} NMR (75 MHz, CDCl3) δ 160.6,
143.4, 141.2, 138.2, 135.7, 129.4, 127.8, 121.4, 107.1, 100.1, 83.8, 68.8,
55.4, 48.5, 30.7, 23.0, 21.6, 17.1; IR (neat) νmax 3294, 2927, 2840, 1594,
1459, 1348, 1154, 1065, 663 cm−1; HRMS (ESI)m/z: [M +Na]+ calcd
for C23H27NO4SNa 436.1553; found 436.1555.
(Z)-N-(7-Bromo-3-methylhept-2-en-6-yn-1-yl)-N-(3,5-dime-
thoxyphenyl)-4-methylbenzenesulfonamide [(Z)-3d]. NBS
(75.0 mg, 0.42 mmol) and AgNO3 (7.1 mg, 0.04 mmol) were added
to a solution of 1,5-enyne (Z)-3a (158.3 mg, 0.38 mmol) in acetone (5
mL), and the reaction mixture was stirred for 1 h at room temperature.
The reaction mixture was diluted with Et2O (10 mL), the organic phase
was washed with H2O (10 mL) and brine (10 mL), dried with MgSO4
(anhyd.), filtered, and concentrated in vacuo. After purification by
column chromatography (15% EtOAc/hexanes), (Z)-3d was obtained
(128.9mg, 69%) as a yellow oil; 1HNMR (300MHz, CDCl3) δ 7.55 (d,
J = 8.0 Hz, 2H), 7.28−7.25 (m, 2H), 6.37 (t, J = 2.3 Hz, 1H), 6.19 (dt, J
= 2.3, 1.3 Hz, 2H), 5.24−5.20 (m, 1H), 4.13 (d, J = 7.0Hz, 2H), 3.71 (s,
6H), 2.42 (s, 3H), 2.10 (m, 4H), 1.62 (s, 3H); 13C{1H} NMR (75
MHz, CDCl3) δ 160.7, 143.5, 141.2, 138.2, 135.8, 129.5, 127.9, 121.5,
107.1, 100.2, 79.7, 55.5, 48.6, 38.5, 30.6, 23.2, 21.7, 18.5; IR (neat) νmax
2925, 2839, 1592, 1457, 1347, 1204, 1152, 1065, 662 cm−1; HRMS
(ESI) m/z: [M + Na]+ calcd for C23H26BrNO4SNa 514.0658; found
514.0651.
(Z)-4-Methyl-N-(3-methylhept-2-en-6-yn-1-yl)-N-phenyl-
benzenesulfonamide [(Z)-3e]. To a 0 °C solution of (Z)-3-
methylhept-2-en-6-yn-1-ol26 (151.4 mg, 1.21 mmol), triphenylphos-
phine (479.2 mg, 1.81 mmol) and p-toluene-sulfonanilide (451.8 mg,
1.81 mmol) in THF (15 mL), DIAD (0.36 mL, 1.81 mmol) was added
dropwise. The reactionmixture was stirred for 5 h at 60 °C in an oil bath
and the solvent was evaporated in vacuo. The corresponding residue was
purified by flash chromatography (10% EtOAc/hexanes) to afford (Z)-
3e as a colorless oil (329.3 mg, 77%); 1H NMR (300 MHz, CDCl3) δ
7.49 (d, J = 8.3 Hz, 2H), 7.29−7.25 (m, 5H), 7.05−7.02 (m, 2H),
5.24−5.19 (m, 1H), 4.19 (d, J = 7.0 Hz, 2H), 2.43 (s, 3H), 2.10−2.05
(m, 4H), 1.89 (t, J = 2.4 Hz, 1H), 1.61 (s, 3H); 13C{1H} NMR (75
MHz, CDCl3) δ 143.4, 139.4, 138.3, 135.8, 129.5, 129.0, 129.0, 127.9,
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127.8, 121.4, 83.8, 68.8, 48.5, 30.7, 23.0, 21.6, 17.1; IR (neat) νmax 3290,
2920, 2869, 1596, 1493, 1345, 1162, 1092, 656 cm−1; HRMS (ESI)m/
z: [M + Na]+ calcd for C21H23NO2SNa 376.1341; found 376.1334.
(E)-N-(3,5-Dimethoxyphenyl)-N-(hept-2-en-6-yn-1-yl)-4-
methylbenzenesulfonamide [(E)-3f]. To a 0 °C solution of (E)-
hept-2-en-6-yn-1-ol28 (150.0 mg, 1.36 mmol), triphenylphosphine
(535.1 mg, 2.04 mmol), and N-(3,5-dimethoxybenzyl)-4-methylben-
zenesulfonamide27 (627.0 mg, 2.04 mmol) in THF (10 mL), DIAD
(0.40 mL, 2.04 mmol) was added dropwise and the reaction mixture
was stirred for 5 h at 60 °C in an oil bath. The solvent was evaporated in
vacuo and the corresponding residue was purified by flash
chromatography (20% EtOAc/hexanes) to afford (E)-3f (396.6 g,
73%) as a white solid; mp 90−92 °C; 1H NMR (300 MHz, CDCl3) δ
7.53 (d, J = 8.2 Hz, 2H), 7.24 (d, J = 8.2 Hz, 2H), 6.35 (t, J = 2.3 Hz,
1H), 6.18 (d, J = 2.3 Hz, 2H), 5.56−5.40 (m, 2H), 4.07 (d, J = 5.9 Hz,
2H), 3.68 (s, 6H), 2.40 (s, 3H), 2.10 (m, J = 3.1, 2.6 Hz, 4H), 1.87 (m,
1H); 13C{1H} NMR (75 MHz, CDCl3) δ 160.5, 143.5, 140.9, 135.6,
133.2, 129.4, 127.8, 125.8, 107.2, 100.1, 83.5, 68.8, 55.4, 52.9, 31.0,
21.6, 18.3; IR (neat) νmax 3289, 2934, 2840, 1593, 1458, 1345, 1153,
1090, 662 cm−1; HRMS (ESI) m/z: [M + Na]+ calcd for
C22H25NO4SNa 422.1396; found 422.1385.
(Z)-4-Methoxy-2-(3-methylhept-2-en-6-yn-1-yl)phenol [(Z)-
5a]. PBr3 (162.4 mg, 0.60 mmol) was added dropwise to a solution
of (Z)-3-methylhept-2-en-6-yn-1-ol26 (150.2 mg, 1.21 mmol) in Et2O
(10 mL) at 0 °C and was stirred for 30 min. The reaction was quenched
withH2O (10mL) and the aqueous phase was extracted with Et2O (3×
10 mL). The combined organic phase was washed with H2O (30 mL),
NaHCO3 (30 mL, satd. sol.), and brine (10 mL), dried with MgSO4
(anhyd.), filtered, and concentrated in vacuo to afford (Z)-7-bromo-5-
methylhept-5-en-1-yne as an orange oil, which was used in the next step
without further purification. The crude product was dissolved in
toluene (10 mL) and NaH 95% (35.5 mg, 1.33 mmol) and 4-
methoxyphenol (165.2 mg, 1.33 mmol) was added. The reaction
mixture was stirred overnight at room temperature, quenched with a
NH4Cl saturated solution, and the aqueous phase was extracted with
Et2O (3 × 10 mL). The resulting organic phase was washed with H2O
(30 mL) and brine (30 mL), dried with MgSO4 (anhyd.), filtered, and
concentrated in vacuo to yield, after purification by column
chromatography (10% EtOAc/hexanes), (Z)-5a (158.8 mg, 57%) as
a colorless oil; 1H NMR (300 MHz, CDCl3) δ 6.73 (d, J = 8.5 Hz, 1H),
6.68−6.64 (m, 2H), 5.41−5.36 (m, 1H), 4.68 (s, 1H), 3.75 (s, 3H),
3.37 (d, J = 7.1 Hz, 2H), 2.42−2.40 (m, 2H), 2.38−2.35 (m, 2H), 1.99
(t, J = 2.5 Hz, 1H), 1.78 (s, 3H); 13C{1H} NMR (75 MHz, CDCl3) δ
153.7, 148.1, 136.2, 128.2, 124.2, 116.3, 115.9, 112.1, 84.1, 68.9, 55.9,
30.8, 29.6, 23.1, 17.2; IR (neat) νmax 3405, 3290, 2913, 2834, 1497,
1430, 1199, 1039, 803 cm−1; HRMS (EI) m/z: [M]+ calcd for
C15H18O2 230.1301; found 230.1296.
(Z)-2-(7-Bromo-3-methylhept-2-en-6-yn-1-yl)-4-methoxy-
phenol [(Z)-5b]. To a room temperature solution of (Z)-3-
methylhept-2-en-6-yn-1-ol26 (84.8 mg, 0.68 mmol) in acetone (5
mL), NBS (133.8 mg, 0.75 mmol) and AgNO3 (12.7 mg, 0.07 mmol)
were added, and the reaction mixture was stirred for 1 h. The reaction
mixture was diluted with Et2O (10mL), washed with H2O (10mL) and
brine (10 mL), dried with MgSO4 (anhyd.), filtered, and concentrated
in vacuo to afford (Z)-7-bromo-3-methylhept-2-en-6-yn-1-ol as an
orange oil, which was used in the next step without further purification.
The crude product was dissolved in Et2O (10 mL) and cooled at 0 °C,
PBr3 (92.4 mg, 0.34 mmol) was then added dropwise, and the reaction
mixture was stirred for 30 min. The reaction was quenched with H2O
(10 mL), and the aqueous phase was extracted with Et2O (3 × 10 mL).
The resulting organic phase was washed withH2O (30mL), a NaHCO3
saturated solution (30 mL), and brine (10 mL), dried with MgSO4
(anhyd.), filtered, and concentrated in vacuo to afford (Z)-1,7-dibromo-
5-methylhept-5-en-1-yne as an orange oil, which was used in the next
step without further purification.
The crude product in toluene (10 mL) was added to a solution of
NaH 95% (20.0 mg, 0.75 mmol) and 4-methoxyphenol (92.9 mg, 0.75
mmol) at room temperature, and the reaction mixture was stirred
overnight. The reaction mixture was quenched with a NH4Cl saturated
solution (2 mL) and was extracted with Et2O (3 × 10 mL). The
combined organic phase was washed with H2O (30 mL) and brine (30
mL), dried with MgSO4 (anhyd.), filtered, and concentrated in vacuo to
afford, after purification by column chromatography (10% EtOAc/
hexanes), (Z)-5b (90.4 mg, 43%) as a colorless oil; 1H NMR (300
MHz, CDCl3) δ 6.74−6.63 (m, 3H), 5.42−5.38 (m, 1H), 4.89 (s, 1H),
3.76 (s, 3H), 3.36 (d, J = 7.2 Hz, 2H), 2.40−2.35 (m, 4H), 1.77 (s, 3H);
13C{1H} NMR (75 MHz, CDCl3) δ 153.7, 148.0, 135.9, 128.3, 124.2,
116.2, 115.8, 112.1, 79.9, 55.9, 38.5, 30.7, 29.3, 23.3, 18.6; IR (neat)
νmax 3408, 2915, 2835, 1504, 1432, 1201, 1041, 805 cm
−1; HRMS (ESI)
m/z: [M + Na]+ calcd for C15H17BrO2Na: 331.0304; found 331.0315.
General Procedure for In(III)-Catalyzed Cascade Cyclo-
isomerization Reactions of 1,5-Enynes. In a Schlenk tube filled
with argon, InI3 (5 mol %) was placed and a solution of the
corresponding 1,5-enyne (∼0.07 M) in toluene was added. The
reaction mixture was stirred at 60 °C in an oil bath (for 1a−d, 3a−f, and
7a−c) or at room temperature (for 5a−b) until the starting material is
consumed (TLC). The reaction was quenched with NH4Cl (10 mL,
satd. sol.), poured into a separatory funnel, and the aqueous phase was
extracted with Et2O (3 × 10 mL). The resulting combined organic
phase was washed with brine (15 mL), dried with anhydrous MgSO4,
filtered, and concentrated under reduced pressure to afford, after
purification by column chromatography, the corresponding tricyclic
product.
(6aS*,10aS*)-1,3-Dimethoxy-10a-methyl-6a,9,10,10a-tetra-
hydro-6H-benzo[c]chromene [trans-2a].14c According to the
general procedure, the reaction of 1,5-enyne (E)-1a (87.4 mg, 0.34
mmol) with InI3 (8.5 mg, 0.017 mmol) gave 2a (56.8 mg, 65%; cis/
trans = 11:89) as a colorless oil. Purification by column chromatog-
raphy (2% EtOAc/hexanes) provided pure trans-2a: 1H NMR (300
MHz, CDCl3) δ 6.05−6.02 (m, 2H), 5.82−5.76 (m, 1H), 5.36 (dq, J =
9.8, 2.1 Hz, 1H), 4.08 (dd, J = 10.3, 4.1 Hz, 1H), 3.99 (dd, J = 12.4, 10.3
Hz, 1H), 3.77 (s, 3H), 3.74 (s, 3H), 3.07−3.00 (m, 1H), 2.71−2.67 (m,
1H), 2.22 (m, 2H), 1.57−1.53 (m, 1H), 1.17 (s, 3H); 13C{1H} NMR
(75MHz, CDCl3) δ 160.3, 159.3, 155.8, 129.3, 123.8, 113.8, 94.1, 92.3,
66.4, 55.3, 55.3, 41.7, 33.3, 32.0, 24.4, 18.1. HRMS (ESI) m/z: [M +
Na]+ calcd for C16H20O3Na 283.1304; found 283.1317.
Scale-Up Experiment for (trans)-2a. In a Schlenk tube filled with
argon, InI3 (38.1 mg, 0.077 mmol) was placed and a solution of the
enyne (E)-1a (400.5 mg, 1.54 mmol) in toluene (22 mL) was added.
The reaction mixture was stirred at 60 °C in an oil bath for 2 h,
quenched with a NH4Cl (30 mL, satd. sol.), poured into a separatory
funnel, and extracted with Et2O (3 × 30 mL). The combined organic
phase was washed with brine (35 mL), dried with anhydrous MgSO4,
filtered, and concentrated under reduced pressure. The residue was
purified by column chromatography (2% EtOAc/hexanes) to afford 2a
(252.4 mg, 63%; cis/trans = 16:84) as a colorless oil.
(4aS*,9aS*)-6,8-Dimethoxy-4a-methyl-4,4a,9,9a-tetrahy-
dro-3H-xanthene (I). According to the general procedure, the
reaction of 1,5-enyne (E)-1a (150.2 mg, 0.58 mmol) with InI3 (14.3
mg, 0.029 mmol) in the presence of AgSbF6 (10.0 mg, 0.029 mmol)
afforded a mixture of I:2a (4:1) by 1H NMR. After purification by
column chromatography (1% EtOAc/hexanes), compound I was
isolated as a colorless oil (81.1 mg, 54%, cis/trans = 19:81); 1H NMR
(500MHz, CDCl3) δ 6.05 (d, J = 0.9 Hz, 2H), 5.66−5.64 (m, 1H), 5.52
(ddt, J = 9.7, 2.5, 1.7 Hz, 1H), 3.79 (s, 3H), 3.75 (s, 3H), 2.72 (dd, J =
16.2, 5.5 Hz, 1H), 2.50−2.42 (m, 1H), 2.35−2.28 (m, 1H), 2.27−2.18
(m, 1H), 2.11 (dd, J = 16.2, 13.7 Hz, 1H), 1.98−1.92 (m, 1H), 1.86 (td,
J = 12.0, 6.9 Hz, 1H), 1.11 (s, 3H). 13C{1H} NMR (126 MHz, CDCl3)
δ 159.5, 158.5, 154.9, 128.8, 126.5, 104.0, 93.8, 91.0, 75.9, 55.4, 55.3,
38.6, 35.2, 25.1, 22.3, 15.9. HRMS (ESI) m/z: [M + H]+ calcd for
C16H21O3 261.1491; found 261.1486.
2-(But-3-yn-1-yl)-5,7-dimethoxy-2-methylchromane (II). Ac-
cording to the general procedure, the reaction of 1,5-enyne (E)-1a
(90.1 mg, 0.35 mmol) with In(NTf2)3 (16.7 mg, 0.018 mmol) in DCE
(5 mL) at 60 °C in an oil bath for 5 h afforded, after purification by
column chromatography (5% EtOAc/hexanes), compound II (56.7
mg, 63%) as a yellow oil; 1HNMR (400MHz, CDCl3) δ 6.03 (d, J = 2.4
Hz, 1H), 5.99 (d, J = 2.4 Hz, 1H), 3.78 (s, 3H), 3.75 (s, 3H), 2.64−2.49
(m, 2H), 2.37−2.32 (m, 2H), 1.97−1.91 (m, 2H), 1.86−1.82 (m, 1H),
1.79−1.73 (m, 2H), 1.28 (s, 3H); 13C{1H} NMR (101MHz, CDCl3) δ
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159.6, 158.6, 154.8, 102.5, 93.8, 91.1, 84.8, 75.3, 68.3, 55.5, 55.4, 38.4,
30.8, 23.8, 16.3, 13.1; IR (neat) νmax 3289, 2926, 2853, 1616, 1590,
1202, 1143, 1105, 811 cm−1; HRMS (ESI) m/z: [M + Na]+ calcd for
C16H20NaO3 283.1304; found 283.1317.
(6aS*,10aS*)-1,3-Dimethoxy-7,10a-dimethyl-6a,9,10,10a-
tetrahydro-6H-benzo[c]chromene [trans-2b].14a According to
the general procedure, the reaction of 1,5-enyne (E)-1b (99.2 mg, 0.36
mmol) with InI3 (8.9 mg, 0.018 mmol) afforded 2b (67.5 mg, 68%; cis/
trans = 22:78) as a colorless oil. Purification by column chromatog-
raphy (2% EtOAc/hexanes) afforded pure trans-2b: 1H NMR (300
MHz, CDCl3) δ 6.04−6.01 (m, 2H), 5.46 (m, 1H), 4.38 (dd, J = 10.4,
3.6 Hz, 1H), 4.01−3.94 (m, 1H), 3.76 (s, 3H), 3.74 (s, 3H), 3.00 (dd, J
= 13.1, 6.1 Hz, 1H), 2.66 (d, J = 12.1 Hz, 1H), 2.14 (m, 2H), 1.67 (s,
3H), 1.49−1.41 (m, 1H) 1.18 (s, 3H); 13C{1H} NMR (101 MHz,
CDCl3) δ 160.3, 159.3, 155.7, 130.0, 123.5, 113.8, 93.9, 92.4, 64.4, 55.3,
55.3, 44.7, 33.7, 31.9, 23.7, 20.8, 18.4; HRMS (ESI) m/z: [M + Na]+
calcd for C17H22O3Na 297.1461; found 297.1454.
(6aS* ,10aS*)-7-Bromo-1,3-dimethoxy-10a-methyl-
6a,9,10,10a-tetrahydro-6H-benzo[c]chromene [trans-2c]. Ac-
cording to the general procedure, the reaction of 1,5-enyne (E)-1c
(68.6mg, 0.20mmol) with InI3 (5.0mg, 0.010mmol) afforded 2c (42.5
mg, 62%; cis/trans = 27:73) as a white solid. Purification by column
chromatography (2% EtOAc/hexanes) afforded pure trans-2c: 1H
NMR (300 MHz, CDCl3) δ 6.18−6.16 (m, 1H), 6.05−6.02 (m, 2H),
4.57 (dd, J = 10.4, 3.5 Hz, 1H), 3.95 (dd, J = 11.8, 10.4 Hz, 1H), 3.76 (s,
3H), 3.74 (s, 3H), 3.14−3.07 (m, 1H), 2.99−2.93 (m, 1H), 2.26−2.22
(m, 2H), 1.49 (m, 1H), 1.25 (s, 3H); 13C{1H} NMR (126 MHz,
CDCl3) δ 159.9, 159.5, 155.8, 131.1, 119.7, 112.4, 93.9, 92.5, 66.2, 55.4,
55.3, 46.8, 36.3, 31.3, 26.2, 18.5; IR (neat) νmax 2933, 2837, 1612, 1583,
1463, 1201, 1151, 1104, 814 cm−1; HRMS (ESI)m/z: [M +Na]+ calcd
for C16H19BrO3Na 361.0409; found 361.0418.
(6aR*,10aS*)-10a-Methyl-6a,9,10,10a-tetrahydro-6H-
benzo[c]chromene [cis-2d]. According to the general procedure, the
reaction of 1,5-enyne (E)-1d (105.4 mg, 0.53 mmol) with InI3 (13.0
mg, 0.027 mmol) or 1,5-enyne (Z)-1d (99.2 mg, 0.49) with InI3 (11.8
mg, 0.025 mmol) afforded cis-2d [64.3 mg, 61% from (E)-1d and 64.5
mg, 65% from (Z)-1d] as a yellow oil after purification by column
chromatography (2% EtOAc/hexanes); 1H NMR (300 MHz, CDCl3)
δ 7.23 (dd, J = 7.8, 1.7 Hz, 1H), 7.08 (ddd, J = 8.0, 7.2, 1.7 Hz, 1H), 6.90
(td, J = 7.5, 1.3 Hz, 1H), 6.79 (dd, J = 8.1, 1.4 Hz, 1H), 5.82−5.79 (m,
1H), 5.59 (ddt, J = 10.0, 3.8, 2.0 Hz, 1H), 4.22 (dd, J = 11.0, 3.0 Hz,
1H), 3.90 (dd, J = 11.0, 6.6 Hz, 1H), 2.34 (m, 1H), 2.02−1.98 (m, 2H),
1.88−1.68 (m, 2H), 1.35 (s, 3H); 13C{1H} NMR (75 MHz, CDCl3) δ
154.3, 130.4, 129.9, 127.3, 127.1, 126.1, 120.9, 117.0, 66.8, 41.3, 33.9,
32.9, 29.1, 22.6; IR (neat) νmax 2922, 2855, 1579, 1488, 1447, 1218, 751
cm−1; HRMS (EI) m/z: [M]+ calcd for C14H16O 200.1201; found
200.1182.
(6aR*,10aS*)-1,3-Dimethoxy-10a-methyl-6a,9,10,10a-tetra-
hydro-6H-benzo[c]chromene [cis-2a]. According to the general
procedure, the reaction of 1,5-enyne (Z)-1a (91.5 mg, 0.35 mmol) with
InI3 (9.1 mg, 0.018 mmol) afforded cis-2a (58.6 mg, 64%) as a colorless
oil after purification by column chromatography (2% EtOAc/hexanes);
1HNMR (300MHz, CDCl3) δ 6.07 (d, J = 2.6 Hz, 1H), 6.01 (d, J = 2.6
Hz, 1H), 5.84−5.81 (m, 1H), 5.51 (ddt, J = 9.9, 3.6, 1.8 Hz, 1H), 4.13
(dd, J = 10.7, 2.8 Hz, 1H), 3.84 (dd, J = 10.7, 6.8 Hz, 1H), 3.77 (s, 3H),
3.74 (s, 3H), 2.26−2.24 (m, 1H), 2.22−2.18 (m, 1H), 1.99−1.78 (m,
3H), 1.39 (s, 3H); 13C{1H} NMR (75 MHz, CDCl3) δ 160.7, 159.0,
156.5, 130.5, 125.9, 111.0, 93.7, 92.9, 66.8, 55.3, 55.3, 43.4, 33.2, 30.8,
25.7, 23.0; IR (neat) νmax 2922, 2837, 1612, 1583, 1463, 1200, 1153,




ing to the general procedure, the reaction of 1,5-enyne (Z)-1c (84.0 mg,
0.25 mmol) with InI3 (6.1 mg, 0.012 mmol) afforded cis-2c (47.9 mg,
57%) as a yellow oil after purification by column chromatography (2%
EtOAc/hexanes); 1H NMR (300 MHz, CDCl3) δ 6.21(m, 1H), 6.07
(d, J = 2.6 Hz, 1H), 6.05 (d, J = 2.6 Hz, 1H), 4.32 (dd, J = 10.9, 2.9 Hz,
1H), 4.06 (dd, J = 10.9, 8.0 Hz, 1H), 3.77 (s, 3H), 3.74 (s, 3H), 2.52−
2.49 (m, 1H), 2.03 (m, 3H), 1.89 (m, 1H), 1.44 (s, 3H); 13C{1H}NMR
(101 MHz, CDCl3) δ 160.3, 159.4, 156.7, 132.5, 121.6, 110.9, 93.9,
93.3, 65.8, 55.3, 51.3, 36.2, 29.2, 25.1, 24.8; IR (neat) νmax 2935, 2837,
1612, 1584, 1464, 1201, 1153, 815 cm−1; HRMS (EI) m/z: [M]+ calcd
for C16H19BrO3 338.0512; found 338.0511.
(6aS* ,10aS* ) -1 ,3-Dimethoxy-10a-methyl-5-tosyl -
5,6,6a,9,10,10a-hexahydrophenanthridine [trans-4a].14c Ac-
cording to the general procedure, the reaction of 1,5-enyne (E)-3a
(120.0 mg, 0.29 mmol) with InI3 (7.2 mg, 0.015 mmol) afforded, after
purification by column chromatography (5% EtOAc/hexanes), trans-
4a (108.1 mg, 90%) as a white solid; 1H NMR (300 MHz, CDCl3) δ
7.51 (d, J = 8.3, 2H), 7.21−7.17 (m, 3H), 6.22 (d, J = 2.5, 1H), 5.71 (dq,
J = 9.9, 3.3 Hz, 1H), 5.33 (dq, J = 9.8, 2.1 Hz, 1H), 4.00 (dd, J = 11.9, 4.2
Hz, 1H), 3.80 (s, 3H), 3.72 (s, 3H), 3.22 (dd, J = 13.6, 11.8 Hz, 1H),
2.99 (dt, J = 13.3, 4.1 Hz, 1H), 2.36 (s, 3H), 2.30 (m, 1H), 2.10−2.05
(m, 2H), 1.30−1.29 (m, 1H), 0.66 (s, 3H); 13C{1H} NMR (75 MHz,
CDCl3) δ 159.3, 158.2, 143.8, 137.9, 135.8, 129.6, 128.8, 127.4, 125.0,
120.4, 100.4, 96.3, 55.5, 55.4, 47.9, 41.0, 35.2, 31.9, 23.9, 21.6, 16.4;




ing to the general procedure, the reaction of 1,5-enyne (E)-3b (48.8mg,
0.11 mmol) with InI3 (2.8 mg, 0.006 mmol) afforded, after purification
by column chromatography (5% EtOAc/hexanes), trans-4b (41.5 mg,
85%) as a white solid; 1H NMR (300 MHz, CDCl3) δ 7.53 (d, J = 8.3
Hz, 2H), 7.21−7.17 (m, 3H), 6.24 (d, J = 2.5 Hz, 1H), 5.39 (m, 1H),
4.38 (dd, J = 12.6, 3.6 Hz, 1H), 3.80 (s, 3H), 3.72 (s, 3H), 3.20 (t, J =
12.8 Hz, 1H), 2.93 (dd, J = 13.1, 6.2 Hz, 1H), 2.36 (s, 3H), 2.22−2.18
(m, 1H), 2.05−1.98 (m, 2H), 1.70 (s, 3H), 1.15−1.07 (m, 1H), 0.80 (s,
3H); 13C{1H} NMR (75 MHz, CDCl3) δ 159.5, 158.1, 143.8, 137.7,
136.3, 130.8, 129.6, 127.4, 123.3, 120.4, 100.4, 96.6, 55.5, 55.4, 45.2,
44.1, 35.9, 31.9, 23.5, 21.7, 21.2, 17.1; IR (neat) νmax 2926, 2839, 1606,
1581, 1455, 1350, 1187, 1164, 671 cm−1; HRMS (ESI)m/z: [M +Na]+
calcd for C24H29NO4SNa 450.1709; found 450.1705.
(6aR*,10aS*)-1,3-Dimethoxy-10a-methyl-7-phenyl-5-tosyl-
5,6,6a,9,10,10a-hexahydrophenanthridine [trans-4c]. Accord-
ing to the general procedure, the reaction of 1,5-enyne (E)-3c (80.9 mg,
0.17 mmol) with InI3 (4.2 mg, 0.008mmol) afforded trans-4c (66.3 mg,
82%) as a white solid after purification by column chromatography (5%
EtOAc/hexanes); 1H NMR (300 MHz, CDCl3) δ 7.51 (d, J = 8.3 Hz,
2H), 7.36−7.28 (m, 3H), 7.21−7.11 (m, 4H), 7.13 (d, J = 2.5 Hz, 1H),
6.26 (d, J = 2.5 Hz, 1H), 5.67 (q, J = 3.4 Hz, 1H), 4.09 (dd, J = 12.7, 3.4
Hz, 1H), 3.79 (s, 3H), 3.76 (s, 3H), 3.09−3.04 (m, 1H), 2.98 (t, J =
12.8 Hz, 1H), 2.79 (dq, J = 12.9, 3.1 Hz, 1H), 2.37 (s, 3H), 2.23−2.21
(m, 2H), 1.41−1.30 (m, 1H), 0.94 (s, 3H); 13C{1H} NMR (75 MHz,
CDCl3) δ 159.4, 158.2, 143.7, 141.6, 137.9, 137.5, 136.6, 129.6, 128.3,
127.9, 127.5, 127.3, 126.9, 120.3, 100.5, 96.5, 55.5, 45.7, 43.4, 36.2,
31.7, 23.9, 21.7, 17.3; IR (neat) νmax 2935, 2837, 1604, 1579, 1418,
1349, 1201, 1163, 1152, 664 cm−1; HRMS (ESI)m/z: [M +Na]+ calcd
for C29H31NO4SNa 512.1866; found: 512.1860.
(6aS*,10aS*)-7-Bromo-1,3-dimethoxy-10a-methyl-5-tosyl-
5,6,6a,9,10,10a-hexahydrophenanthridine [trans-4d].14c Ac-
cording to the general procedure, the reaction of 1,5-enyne (E)-3d
(79.8 mg, 0.17 mmol) with InI3 (4.1 mg, 0.008 mg) afforded, after
purification by column chromatography (5% EtOAc/hexanes), trans-
4d (58.3 mg, 73%) as a colorless oil; 1H NMR (300 MHz, CDCl3) δ
7.60−7.57 (m, 2H), 7.24−7.21 (m, 2H), 7.20 (d, J = 2.5 Hz, 1H), 6.25
(d, J = 2.5 Hz, 1H), 6.08 (dd, J = 4.8, 2.8 Hz, 1H), 4.65 (dd, J = 13.0, 3.5
Hz, 1H), 3.81 (s, 3H), 3.73 (s, 3H), 3.24 (t, J = 12.8Hz, 1H), 3.00 (dd, J
= 13.3, 6.0 Hz, 1H), 2.41 (m, 1H), 2.38 (s, 3H), 2.14−2.05 (m, 2H),
1.20−1.12 (m, 1H), 0.93 (s, 3H); 13C{1H} NMR (75 MHz, CDCl3) δ
159.2, 158.5, 143.9, 137.9, 136.3, 130.8, 129.8, 127.5, 121.0, 119.1,
100.8, 96.8, 55.5, 55.4, 47.2, 46.3, 38.2, 31.4, 25.9, 21.7, 17.3; HRMS
(ESI) m/z: [M + H]+ calcd for C23H27BrNO4S 492.0838; found
492.0839.
(6aR*,10aS*)-10a-Methyl-5-tosyl-5,6,6a,9,10,10a-hexahy-
drophenanthridine [cis-4e]. According to the general procedure,
reactions of 1,5-enyne (E)-3e (85.5 mg, 0.24 mmol) with InI3 (5.9 mg,
0.012 mmol) or 1,5-enyne (Z)-3e (89.0 mg, 0.25) with InI3 (6.3 mg,
0.013 mmol) afforded, after purification by column chromatography
The Journal of Organic Chemistry pubs.acs.org/joc Article
https://doi.org/10.1021/acs.joc.1c00825
J. Org. Chem. 2021, 86, 9515−9529
9525
(5% EtOAc/hexanes), cis-4e [41.9 mg, 49% from (E)-3e and 56.1 mg,
63% from (Z)-3e] as a colorless oil; 1H NMR (300 MHz, CDCl3) δ
7.75−7.72 (m, 1H), 7.51−7.48 (m, 2H), 7.26−7.13 (m, 5H), 5.75
(ddd, J = 9.4, 4.7, 2.4 Hz, 1H), 5.45 (ddt, J = 9.2, 4.9, 2.3 Hz, 1H), 4.16
(dd, J = 14.1, 3.4Hz, 1H), 3.23 (ddd, J = 15.2, 10.8, 4.4 Hz, 1H), 2.37 (s,
3H), 1.99−1.93 (m, 2H), 1.81 (d, J = 11.3 Hz, 1H), 1.57 (dt, J = 9.4, 2.3
Hz, 2H), 0.91 (s, 3H); 13C{1H} NMR (126 MHz, CDCl3) δ 143.7,
139.0, 137.4, 135.7, 129.7, 128.9, 127.6, 127.3, 126.4, 125.7, 125.5,
124.5, 48.4, 39.3, 34.7, 33.3, 25.7, 22.4, 21.6; IR (neat) νmax 2925, 1486,
1447, 1347, 1163, 1090, 658 cm−1; HRMS (ESI)m/z: [M +Na]+ calcd
for C21H23NO2SNa: 376.1341; found: 376.1348.
(6aR* ,10aS* ) -1 ,3-Dimethoxy-10a-methyl-5-tosyl -
5,6,6a,9,10,10a-hexahydrophenanthridine [cis-4a]. According
to the general procedure, the reaction of 1,5-enyne (Z)-3a (95.3 mg,
0.23 mmol) with InI3 (5.7 mg, 0.011 mmol) afforded, after purification
by column chromatography (5% EtOAc/hexanes), cis-4a (83.9 mg,
88%) as a white solid; mp 101−103 °C; 1HNMR (300MHz, CDCl3) δ
7.52 (d, J = 8.1 Hz, 2H), 7.20 (d, J = 8.1 Hz, 2H), 6.97 (d, J = 2.6 Hz,
1H), 6.31 (d, J = 2.6 Hz, 1H), 5.79−5.75 (m, 1H), 5.41−5.38 (m, 1H),
4.14 (dd, J = 14.0, 3.2 Hz, 1H), 3.79 (s, 3H), 3.75 (s, 3H), 3.17 (dd, J =
14.0, 11.2 Hz, 1H), 2.37 (s, 3H), 2.15 (dt, J = 13.2, 4.2 Hz, 1H), 1.93−
1.87 (m, 2H), 1.74 (d, J = 11.0 Hz, 1H), 1.42 (ddd, J = 13.1, 10.6, 5.4
Hz, 1H), 0.95 (s, 3H); 13C{1H} NMR (75 MHz, CDCl3) δ 159.9,
158.0, 143.7, 137.9, 137.6, 129.7, 129.5, 127.3, 125.6, 120.2, 101.2, 97.8,
55.5, 55.3, 48.3, 41.5, 34.9, 28.0, 22.6, 22.3, 21.6; IR (neat) νmax 2928,
2837, 1607, 1579, 1460, 1349, 1161, 672 cm−1; HRMS (ESI) m/z: [M
+ Na]+ calcd for C23H27NO4SNa 436.1553; found 436.1555.
(6aR*,10aS*)-7-Bromo-1,3-dimethoxy-10a-methyl-5-tosyl-
5,6,6a,9,10,10a-hexahydrophenanthridine [cis-4d]. According
to the general procedure, the reaction of 1,5-enyne (Z)-3d (90.2 mg,
0.18 mmol) with InI3 (4.6 mg, 0.009 mmol) afforded, after purification
by column chromatography (5% EtOAc/hexanes), cis-4d (64.9 mg,
72%) as a white solid; mp 144−146 °C; 1HNMR (300MHz, CDCl3) δ
7.53 (d, J = 8.3 Hz, 2H), 7.23 (d, J = 8.3 Hz, 2H), 7.12 (d, J = 2.6 Hz,
1H), 6.34 (d, J = 2.6Hz, 1H), 6.12 (t, J = 4.0Hz, 1H), 4.65 (dd, J = 14.3,
3.2 Hz, 1H), 3.84 (s, 3H), 3.75 (s, 3H), 3.06 (dd, J = 14.3, 11.9 Hz, 1H),
2.37 (s, 3H), 2.30−2.24 (m, 1H), 1.99−1.95 (m, 2H), 1.79−1.75 (m,
1H), 1.25 (ddd, J = 13.6, 10.6, 6.7 Hz, 1H), 0.92 (s, 3H); 13C{1H}
NMR (75 MHz, CDCl3) δ 159.4, 158.3, 143.9, 137.8, 136.8, 131.1,
129.7, 127.7, 121.5, 120.1, 102.1, 98.3, 55.6, 55.3, 49.0, 47.4, 37.3, 26.1,
24.7, 21.7, 21.4; IR (neat) νmax 2932, 1608, 1579, 1461, 1352, 1203,
1164, 672 cm−1; HRMS (ESI) m/z: [M + Na]+ calcd for
C23H26BrNO4SNa 514.0658; found: 514.0657.
(6aS*,10aS*)-1,3-Dimethoxy-5-tosyl-5,6,6a,9,10,10a-hexa-
hydrophenanthridine [trans-4f]. According to the general
procedure, the reaction of 1,5-enyne (E)-3f (85.0 mg, 0.22 mmol)
with InI3 (5.5 mg, 0.011 mmol) afforded, after purification by column
chromatography (5% EtOAc/hexanes), trans-4f (67.2 mg, 79%,) as a
white solid; mp 101−103 °C; 1H NMR (500MHz, CDCl3) δ 7.55 (d, J
= 8.3Hz, 2H), 7.21 (d, J = 8.3Hz, 2H), 7.07 (d, J = 2.5Hz, 1H), 6.26 (d,
J = 2.5 Hz, 1H), 5.66−5.63 (m, 1H), 5.52 (dq, J = 9.7, 2.0 Hz, 1H), 4.22
(dd, J = 12.8, 3.7 Hz, 1H), 3.80 (s, 3H), 3.73 (s, 3H), 3.05 (dd, J = 12.8,
12.1 Hz, 1H), 2.82 (ddt, J = 13.0, 5.5, 2.5 Hz, 1H), 2.38 (s, 3H), 2.21
(td, J = 11.2, 11.2, 2.2 Hz, 1H), 2.19−1.99 (m, 2H), 2.02 (bt, J = 11.5
Hz, 1H), 1.03−0.96 (m, 1H); 13C{1H} NMR (126 MHz, CDCl3) δ
159.6, 158.5, 143.7, 139.1, 137.0, 129.7, 128.8, 127.7, 127.3, 114.8,
101.3, 96.6, 55.6, 55.4, 51.2, 39.2, 38.6, 27.2, 27.1, 21.7; IR (neat) νmax
2929, 2836, 1607, 1579, 1455, 1346, 1185, 1162, 665 cm−1; HRMS
(ESI) m/z: [M + Na]+ calcd for C22H25NO4SNa 422.1396; found
422.1397.
(4S*,9S*)-7-Methoxy-4-methyl-4,9-tetrahydro-3H-xanthene
[trans-6a].20 According to the general procedure, the reaction of 1,5-
enyne (E)-5a20 (97.6 mg, 0.42 mmol) with InI3 (10.5 mg, 0.021 mmol)
afforded, after purification by column chromatography (5% EtOAc/
hexanes), trans-6a (83.9 mg, 86%) as a white solid; 1H NMR (400
MHz, CDCl3) δ 6.76 (d, J = 8.8 Hz, 1H), 6.70 (dd, J = 8.9, 2.9 Hz, 1H),
6.63 (d, J = 2.9 Hz, 1H), 5.68−5.65 (m, 1H), 5.49 (ddt, J = 9.7, 2.9, 1.6
Hz, 1H), 3.76 (s, 3H), 2.69 (dd, J = 13.9, 3.4 Hz, 1H), 2.67−2.47 (m,
2H), 2.34−2.29 (m, 1H), 2.26−2.22 (m, 1H), 1.98−1.93 (m, 1H), 1.86
(td, J = 11.9, 6.9 Hz, 1H), 1.10 (s, 3H); 13C{1H} NMR (75 MHz,
CDCl3) δ 153.1, 148.0, 128.5, 127.0, 123.1, 118.1, 114.5, 113.7, 75.5,
55.8, 39.1, 35.4, 28.5, 25.2, 16.0; HRMS (EI) m/z: [M]+ calcd for
C15H18O2 [M]
+: 230.1301; found: 230.1294.
(4S*,9R*)-1-Bromo-7-methoxy-4-methyl-4,9-tetrahydro-3H-
xanthene [trans-6b].14c According to the general procedure, the
reaction of 1,5-enyne (E)-5b14c (105.4 mg, 0.31 mmol) with InI3 (7.7
mg, 0.016 mmol) afforded, after purification by column chromatog-
raphy (5% EtOAc/hexanes), trans-6b (93.8 mg, 89%) as a white solid;
1H NMR (300 MHz, CDCl3) δ 6.78−6.67 (m, 3H), 6.11−6.08 (m,
1H), 3.76 (s, 3H), 3.05 (dd, J = 16.1, 5.2 Hz, 1H), 2.86−2.82 (m, 1H),
2.57 (ddt, J = 16.1, 13.4, 1.0 Hz, 1H), 2.29−2.24 (m, 2H), 1.99−1.89
(m, 2H), 1.15 (s, 3H); 13C{1H} NMR (75 MHz, CDCl3) δ 153.4,
147.2, 129.2, 123.8, 122.6, 117.9, 114.3, 114.1, 76.1, 55.8, 45.1, 34.9,
29.0, 25.9, 16.5; HRMS (ESI) m/z: [M + H]+ calcd for C15H18BrO2
309.0484; found: 309.0481.
(4S*,9R*)-7-Methoxy-4-methyl-4,9-tetrahydro-3H-xanthene
[cis-6a]. According to the general procedure, the reaction of 1,5-enyne
(Z)-5a (82.7 mg, 0.35 mmol) with InI3 (8.9 mg, 0.017 mmol) afforded,
after purification by column chromatography (5%EtOAc/hexanes), cis-
6a (71.9 mg, 87%) as a white solid; mp 75−77 °C; 1HNMR (300MHz,
CDCl3) δ 6.69−6.67 (m, 2H), 6.58 (d, J = 2.6 Hz, 1H), 5.72−5.68 (m,
1H), 5.35 (dq, J = 9.9, 2.2 Hz, 1H), 3.74 (s, 3H), 3.08 (dd, J = 16.3, 6.1
Hz, 1H), 2.52 (dd, J = 16.3, 3.7 Hz, 1H), 2.43 (dt, J = 5.6, 2.8 Hz, 1H),
2.31 (ddq, J = 15.7, 9.5, 2.9 Hz, 1H), 2.06−1.95 (m, 2H), 1.70 (ddd, J =
13.4, 9.6, 6.6Hz, 1H), 1.33 (s, 3H); 13C{1H}NMR (75MHz, CDCl3) δ
152.9, 148.1, 128.8, 128.5, 120.0, 117.2, 114.1, 113.5, 73.7, 55.8, 36.8,
33.8, 29.7, 26.0, 22.9; IR (neat) νmax 2921, 2832, 1494, 1236, 1213,
1101, 1041 cm−1; HRMS (EI) m/z: [M]+ calcd for C15H18O2
230.1301; found 230.1293.
(4S*,9S*)-1-Bromo-7-methoxy-4-methyl-4,9-tetrahydro-3H-
xanthene [cis-6b]. According to the general procedure, the reaction
of 1,5-enyne (Z)-5b (76.0 mg, 0.25 mmol) with InI3 (6.1 mg, 0.012
mmol) afforded, after purification by column chromatography (5%
EtOAc/hexanes), cis-6b (69.9 mg, 92%) as a white solid; 1HNMR (300
MHz, CDCl3) δ 6.70−6.69 (m, 2H), 6.61 (d, J = 2.6Hz, 1H), 6.05 (td, J
= 4.1, 1.6 Hz, 1H), 3.76 (s, 3H), 3.13 (dd, J = 16.6, 6.0 Hz, 1H), 2.94
(dd, J = 16.6, 6.0 Hz, 1H), 2.62 (m, 1H), 2.36−2.30 (m, 1H), 2.11−
2.02 (m, 1H), 1.94 (dt, J = 12.4, 6.1 Hz, 1H), 1.74−1.65 (m, 1H), 1.42
(s, 3H); 13C{1H} NMR (126 MHz, CDCl3) δ 153.3, 147.6, 129.9,
124.4, 120.2, 117.1, 113.8, 113.7, 75.9, 55.9, 45.5, 31.6, 29.1, 26.4, 25.0;
HRMS (EI) m/z: [M]+ calcd for C15H17BrO2 308.0406; found:
308.0395.
5′,7′-Dimethoxyspiro[cyclohexane-1,4′-isochroman]-3-ene
(8a).14c According to the general procedure, the reaction of 1,5-enyne
7a (98.3 mg, 0.38 mmol) with InI3 (9.5 mg, 0.019mmol) afforded, after
purification by column chromatography (5% EtOAc/hexanes), 8a
(82.6 mg, 84%) as a colorless oil; 1H NMR (300 MHz, CDCl3) δ 6.35
(d, J = 2.5 Hz, 1H), 6.12 (d, J = 2.5 Hz, 1H), 5.70 (d, J = 2.6 Hz, 2H),
4.69 (d, J = 0.8 Hz, 2H), 3.92 (d, J = 11.4 Hz, 1H), 3.79 (s, 3H), 3.78 (s,
3H), 3.59 (dd, J = 11.4, 1.3 Hz, 1H), 2.88−2.68 (m, 2H), 2.08−2.01
(m, 3H), 1.46−1.42 (m, 1H); 13C{1H} NMR (75 MHz, CDCl3) δ
159.8, 158.6, 137.5, 126.4, 125.5, 122.5, 99.9, 98.1, 73.9, 70.0, 55.3,
55.1, 34.5, 31.6, 27.5, 22.1; HRMS (ESI) m/z: [M + H]+ calcd for
C16H21O3 261.1485; found: 261.1479.
5 ′ ,7 ′-Dimethoxy-2 ′-tosyl-2 ′ ,3 ′-dihydro-1 ′H -spiro-
[cyclohexane-1,4′-isoquinolin]-3-ene (8b).14c According to the
general procedure, the reaction of 1,5-enyne 7b (88.5 mg, 0.21 mmol)
with InI3 (5.3 mg, 0.011 mmol) afforded, after purification by column
chromatography (10% EtOAc/hexanes), 8b (81.4, 92%) as a colorless
oil; 1HNMR (300MHz, CDCl3) δ 7.72 (d, J = 8.0 Hz, 2H), 7.34 (d, J =
8.0 Hz, 2H), 6.32 (d, J = 2.5 Hz, 1H), 6.15 (d, J = 2.5 Hz, 1H), 5.76−
5.65 (m, 2H), 4.16 (d, J = 14.5 Hz, 1H), 4.00 (d, J = 14.5 Hz, 1H), 3.76
(s, 3H), 3.75 (s, 3H), 3.16 (d, J = 11.7 Hz, 1H), 3.00−2.93 (m, 2H),
2.69 (td, J = 13.1, 12.4, 6.8 Hz, 1H), 2.44 (s, 3H), 2.12 (m, 2H), 1.90 (d,
J = 18.2 Hz, 1H), 1.45 (dd, J = 13.5, 5.5 Hz, 1H); 13C{1H} NMR (126
MHz, CDCl3) δ 159.8, 158.7, 143.7, 134.4, 133.0, 129.8, 128.0, 126.0,
125.5, 122.9, 102.1, 98.5, 55.4, 55.2, 52.5, 50.1, 37.0, 31.9, 27.8, 22.0,
21.7; HRMS (EI) m/z: [M]+ calcd for C23H27NO4S 413.1655; found
413.1643.
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3-Bromo-5′,7′-dimethoxy-2′-tosyl-2′,3′-dihydro-1′H-spiro-
[cyclohexane-1,4′-isoquinolin]-3-ene (8c).14c According to the
general procedure, the reaction of 1,5-enyne 7c (95.0 mg, 0.19 mmol)
with InI3 (4.8 mg, 0.010 mmol) afforded, after purification by column
chromatography (10% EtOAc/hexanes), 8c (72.2 mg, 76%) as a
colorless oil; 1H NMR (300 MHz, CDCl3) δ 7.73 (d, J = 8.1 Hz, 2H),
7.35 (d, J = 8.1 Hz, 2H), 6.35 (d, J = 2.5 Hz, 1H), 6.15 (d, J = 2.5 Hz,
1H), 6.08 (m, 1H), 4.10 (q, J = 14.6 Hz, 2H), 3.78 (s, 3H), 3.74 (s, 3H),
3.51−3.44 (m, 1H), 3.19 (d, J = 12.0Hz, 1H), 2.95 (d, J = 11.9Hz, 1H),
2.55 (td, J = 12.3, 6.5 Hz, 1H), 2.44 (s, 3H), 2.26−2.09 (m, 3H), 1.64−
1.53 (m, 1H); 13C{1H} NMR (75 MHz, CDCl3) δ 159.4, 159.0, 143.8,
134.4, 132.9, 129.8, 127.8, 127.0, 121.0, 120.8, 102.2, 98.4, 55.3, 55.2,
52.2, 49.8, 41.3, 39.6, 26.3, 24.0, 21.6; HRMS (EI) m/z: [M]+ calcd for
C23H26BrNO4S: 491.0760; found 491.0770.
General Procedure for the One-Pot Sequential Indium-
Catalyzed Cycloisomerization and Palladium-Catalyzed Cross-
Coupling Reactions of (E)-5b and 7c. In a Schlenk tube filled with
argon, InI3 (5 mol %) was placed and a solution of 1,5-enyne (E)-5b or
7c (∼0.07 M) in toluene was stirred at room temperature (for 5b) or
60°C in an oil bath (for 7c) until the starting material was consumed
(TLC). Then, Pd(PPh3)4 (5 mol %) and a solution of R3In (70 mol %,
0.45 M in dry THF) were added and the mixture was stirred at 80 °C in
an oil bath for 10 h. The reaction was quenched by the addition of a few
drops of MeOH and the mixture was concentrated in vacuo. H2O (10
mL) was added and the aqueous phase was extracted with EtOAc (3 ×
10 mL). The combined organic phase was washed with brine (15 mL),
dried with anhydrous MgSO4, filtered, and concentrated in vacuo. The
residue was purified by flash chromatography to afford, after
concentration and high vacuo drying, the corresponding products
trans-6c−e and 8d.
(4S*,9S*)-7-Methoxy-4-methyl-1-phenyl-4,9-tetrahydro-3H-
xanthene [trans-6c].20 According to the general procedure, the
reaction of 1,5-enyne (E)-5b14c (96.0 mg, 0.31 mmol) with InI3 (7.1
mg, 0.016 mmol), triphenylindium (0.217 mmol), and Pd(PPh3)4
(17.5 mg, 0.016 mmol) afforded, after purification by column
chromatography (5% EtOAc/hexanes), trans-6c (72.2 mg, 76% in
two steps) as a white solid; 1H NMR (300 MHz, CDCl3) δ 7.36−7.28
(m, 3H), 7.26−7.20 (m, 2H), 6.78 (d, J = 8.9 Hz, 1H), 6.69 (dd, J = 8.9,
2.9 Hz, 1H), 6.51 (d, J = 3.0Hz, 1H), 5.73 (dt, J = 5.1, 2.7 Hz, 1H), 3.70
(s, 3H), 3.08−3.03 (m, 1H), 2.70 (dd, J = 16.7, 5.2 Hz, 1H), 2.45−2.35
(m, 2H), 2.27−2.16 (m, 1H), 2.03−1.99 (m, 2H), 1.19 (s, 3H);
13C{1H} NMR (75 MHz, CDCl3) δ 153.1, 147.5, 141.4, 140.0, 128.2,
127.5, 126.9, 126.1, 123.3, 118.0, 114.2, 114.0, 76.0, 55.8, 40.6, 35.3,
27.3, 24.7, 16.6; HRMS (EI) m/z: [M]+ calcd for C21H22O2 306.1614;
found: 306.1587.
(4S*,9S*)-7-Methoxy-1,4-dimethyl-4,9-tetrahydro-3H-xan-
thene [trans-6d].20 According to the general procedure, the reaction
of 1,5-enyne (E)-5b (96.3 mg, 0.31 mmol) with InI3 (7.1 mg, 0.016
mmol), trimethylindium (0.217 mmol), and Pd(PPh3)4 (17.5 mg,
0.016 mmol) afforded, after purification by column chromatography
(5% EtOAc/hexanes), trans-6d (62.9 mg, 83% in two steps) as a white
solid; 1H NMR (300 MHz, CDCl3) δ 6.77−6.65 (m, 3H), 5.39 (m,
1H), 3.76 (s, 3H), 2.87−2.79 (m, 1H), 2.53−2.50 (m, 2H), 2.21−2.18
(m, 2H), 1.92−1.82 (m, 2H), 1.72 (s, 3H), 1.09 (s, 3H); 13C{1H}
NMR (75 MHz, CDCl3) δ 153.1, 147.7, 133.7, 123.1, 121.7, 117.9,
114.5, 113.7, 75.9, 55.8, 42.1, 35.6, 26.4, 24.2, 20.1, 16.5; HRMS (EI)
m/z: [M]+ calcd for C16H20O2 244.1458; found 244.1439.
(4S*,9S*)-1-Butyl-7-methoxy-4-methyl-4,9-tetrahydro-3H-
xanthene [trans-6e]. According to the general procedure, the
reaction of 1,5-enyne (E)-5b14c (95.7 mg, 0.31 mmol) with InI3 (7.1
mg, 0.016 mmol), tributylindium (0.217 mmol), and Pd(PPh3)4 (17.5
mg, 0.016 mmol) afforded, after purification by column chromatog-
raphy (5% EtOAc/hexanes), trans-6e (71.9 mg, 81% two steps) as a
white solid; mp 48−50 °C; 1H NMR (300 MHz, CDCl3) δ 6.78−6.72
(m, 2H), 6.66 (d, J = 2.7 Hz, 1H), 5.39 (m, 1H), 3.76 (s, 3H), 2.85 (d, J
= 11.0 Hz, 1H), 2.54−2.50 (m, 2H), 2.21 (m, 2H), 2.06−1.81 (m, 4H),
1.41−1.26 (m, 4H), 1.09 (s, 3H), 0.92 (t, J = 7.0 Hz, 3H); 13C{1H}
NMR (75 MHz, CDCl3) δ 153.0, 147.7, 137.7, 123.1, 120.8, 117.9,
114.4, 113.8, 76.1, 55.8, 40.7, 35.6, 33.5, 30.7, 26.2, 24.2, 22.6, 16.6,
14.2; IR (neat) νmax 2929, 2856, 1493, 1224, 1148, 1081, 1041 cm
−1;
HRMS (EI)m/z: [M]+ calcd for C19H26O2 286.1927; found: 286.1923.
5′,7′-Dimethoxy-3-phenyl-2′-tosyl-2′,3′-dihydro-1′H-spiro-
[cyclohexane-1,4′-isoquinolin]-3-ene (8d). According to the
general procedure, the reaction of 1,5-enyne 7c (95.2 mg, 0.19
mmol) with InI3 (4.9 mg, 0.010 mmol), triphenylindium (0.13 mmol),
and Pd(PPh3)4 (11.0 mg, 0.010 mmol) afforded, after purification by
column chromatography (5% EtOAc/hexanes), 8d (56.7 mg, 61% in
two steps) as a white solid; mp 125−127 °C; 1H NMR (300 MHz,
CDCl3) δ 7.70−7.67 (m, 2H), 7.41−7.39 (m, 2H), 7.32−7.21 (m, 5H),
6.35 (d, J = 2.5Hz, 1H), 6.18 (d, J = 2.5Hz, 1H), 6.13 (q, J = 3.4, 2.4Hz,
1H), 4.21−4.08 (m, 2H), 3.76 (s, 6H), 3.37 (dd, J = 17.2, 3.3 Hz, 1H),
3.12 (q, J = 11.9 Hz, 2H), 2.73−2.67 (m, 1H), 2.39 (s, 3H), 2.30 (d, J =
17.3 Hz, 3H), 1.26 (m, 1H); 13C{1H} NMR (126 MHz, CDCl3) δ
159.8, 158.9, 143.7, 142.6, 135.7, 134.6, 133.2, 129.8, 128.3, 127.9,
126.8, 125.5, 123.0, 122.6, 102.2, 98.6, 55.4, 55.3, 52.5, 50.0, 37.7, 34.0,
27.2, 22.8, 21.7; IR (neat) νmax 2932, 2841, 1608, 1460, 1340, 1164,
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